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Steering Group launches 
report on a national substance 
misuse strategy
The steering group report on a national 
substance misuse strategy1 was launched by 
Dr Tony Holohan, Chief Medical Offi cer and 
chairman of the group, in the Department 
of Health on 7 February 2012. In 2009 the 
government decided to include alcohol 
in a national substance misuse strategy. 
Arising from this decision a steering group, 
chaired by the Department of Health, was 
established to advise government on a new 
strategy. The steering group was drawn 
from relevant government departments and 
agencies, medical professional bodies, the 
community and voluntary sectors and the 
alcohol industry.
Dr Holohan outlined the extent of harmful 
drinking and its related harm in Ireland. 
In 2010 the per capita consumption for 
adults aged 15 years and over was 11.9 
litres of pure alcohol, which corresponds 
to 45 bottles of vodka. Population surveys 
indicate that almost one and a half million 
adults in Ireland drink in a harmful manner. 
In addition, alcohol is responsible for 88 
deaths every month and for 2,000 occupied 
beds every night in acute hospitals, and is 
a contributory factor in half of all suicides. 
The fi nancial cost of alcohol was €3.7 billion 
in 2007, a fi gure that is likely to be an 
underestimate.
At the launch of the report: Dr Tony Holohan, Chief Medical Offi cer and chairman of the 
National Substance Misuse Strategy Steering Group, and Ms Róisín Shortall TD, Minister of 
State at the Department of Health
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The report sets out the terms of reference of the 
steering group (p.5):
The Steering Group will:
 ■ having reviewed existing policies 
and reports, including at EU and 
international level, set out an 
evidence-based framework which 
identifi es effective policies and 
actions to tackle the harm caused 
to individuals and society by alcohol 
use* and misuse. (*‘alcohol use’ 
in this context refers to the use of 
alcohol across the entire population. 
It does not imply that all alcohol use 
is harmful);
 ■ decide on appropriate structures 
and frameworks for an effective and 
effi cient implementation plan for the 
National Substance Misuse Strategy;
 ■ align, as far as possible, these policies 
and actions with the existing fi ve 
pillars of the National Drugs Strategy 
– supply, prevention, treatment, 
rehabilitation and research;
 ■ make proposals for an overall 
National Substance Misuse Strategy 
to incorporate the National Drugs 
Strategy 2009–2016; and
 ■ submit proposals in regard to 
such a National Substance Misuse 
Strategy to the Minister for Health 
and Children and the Minister for 
Drugs by the end of October 2010. 
Thereafter the proposals will be 
submitted to Government by the 
end of 2010.
Given the range of health problems that can 
arise from alcohol consumption, the steering 
group adopted a population-based approach. 
Such an approach, which is advocated by 
the World Health Organization, ‘benefi ts 
those who are not in regular contact with the 
health services and those who have not been 
specifi cally advised to reduce their alcohol 
intake’.2 It also helps prevent people from 
drinking harmful or hazardous quantities 
of alcohol in the fi rst place. International 
evidence indicates that the higher the level 
of per capita consumption in a country, the 
higher the incidence of alcohol-related harm. 
Therefore, the overall aim is to reduce per capita 
consumption from 11.9 litres per adult aged 15 
and over (2010 level) to 9.2 litres by 2016. 
The main recommendations of the steering 
group include:
 ■ increase the price of alcohol so that it 
becomes less affordable;
 ■ introduce a legislative basis for minimum 
pricing, along with a ‘social responsibility’ 
levy on the drinks industry; 
 ■ commence Section 9 (structural separation 
of alcohol from other products in 
supermarkets and other mixed trading 
outlets) of the Intoxicating Liquor Act 2008; 
 ■ introduce legislation and statutory codes to 
provide for: 
• a 9.00 p.m. watershed for alcohol 
advertising on television and radio; 
• limiting alcohol advertising in cinemas to 
only being associated with fi lms classifi ed 
as suitable for over-18s; 
• prohibiting all outdoor advertising 
of alcohol; 
• subjecting all alcohol advertising in the 
print media to stringent codes, enshrined 
in legislation and independently 
monitored; 
 ■ phase out drinks industry sponsorship of 
sport and other large public events by 2016;
 ■ develop a system to monitor the 
enforcement of the provisions of the 
intoxicating liquor legislation; 
 ■ establish a Clinical Directorate to develop 
the clinical and organisational governance 
framework to underpin treatment and 
rehabilitation services; and
 ■ develop early intervention guidelines for 
alcohol and substance use across all relevant 
sectors of the health and social care system. 
This will include a national screening 
and brief intervention protocol for early 
identifi cation of problem alcohol use.
According to Health Minister James Reilly’s 
written answer to a Dáil question:3 ‘The 
recommendations of the Steering Group on 
alcohol will encourage public debate and 
the Minister envisages an Action Plan being 
developed in advance of proposals being drafted 
for Government.’
(Deirdre Mongan)
1. Department of Health (2012) Steering Group 
report on an National Substance Misuse 
Strategy. Dublin: Department of Health. 
www.drugsandalcohol.ie/16908
2. Department of Health (2012) Launch of 
the report of the National Substance Misuse 
Strategy Steering Group. Press release 
issued by the Department of Health on 
7 February 2012. www.dohc.ie/press/
releases/2012/20120207.html?lang=en
3. Reilly J (2012) Parliamentary Debates Dáil 
Éireann (Offi cial report: unrevised): Written 
answers. Vol. 756, No. 2, p. 407. Substance 
abuse. Question 595. http://debates.
oireachtas.ie/dail/2012/02/21/00407.asp
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3Steering Group’s recommendations 
on minimum pricing, marketing and 
sponsorship
The steering group report on a national substance misuse 
strategy1 contains 45 recommendations under the pillars 
of supply, prevention, treatment and rehabilitation, and 
research. The recommendations that have generated most 
debate relate to the introduction of a minimum price for 
alcohol, restricting alcohol marketing and phasing out 
sponsorship of sports and other cultural events by the drinks 
industry. This article aims to describe the rationale behind 
each of these recommendations. 
Minimum pricing 
Alcohol is price sensitive – increasing the cost of alcohol 
reduces its consumption and decreasing the cost of alcohol 
increases its consumption. Price is therefore often used as a 
policy lever to reduce alcohol consumption and its related 
health and social harms. The steering group recommends 
introducing ‘a legislative basis for minimum pricing per gram 
of alcohol’. Minimum pricing is the lowest price at which 
any alcohol beverage can be sold. Under such a regime, the 
price of a container of alcohol is set (by government) based 
on the number of grams of alcohol content in the beverage, 
so the higher the number of grams of alcohol the higher 
the minimum price will be. This increases the price of cheap 
imported alcohol, rather than of high-quality beer and wine. 
Recent research in British Columbia has shown that a 10% 
increase in the minimum price reduced consumption of all 
alcoholic beverages by 3.4%.2
Why is minimum pricing needed?
In Ireland, alcohol has become more affordable, particularly 
in the off-trade sector. The introduction of more liberal 
licensing legislation has led to alcohol being sold in more 
places, including supermarkets and garage forecourts, and 
for longer periods of time. This has increased competition 
between retailers, particularly mixed trading outlets 
(supermarkets) who can use alcohol as a loss leader and can 
offer deep discounts and promotions. This results in alcohol 
being available at very low prices. Harmful drinkers tend to 
buy alcohol that is cheaper than that bought by low-risk 
drinkers. Cheap alcohol is also attractive to young people. 
So, a minimum pricing policy is benefi cial in that it targets 
the drinkers causing the most harm both to themselves and 
to society, while having little effect on the spending of adult 
moderate drinkers. When alcohol is sold below cost price the 
retailer is entitled to a VAT refund on the difference between 
the cost price and the below-cost sale price. In effect, this 
means that the government is subsidising large retailers who 
can afford to sell alcohol at below-cost price. 
Will this not just lead to more profi t for the alcohol industry?
Yes, but the introduction of a social responsibility levy on 
the alcohol industry should offset those profi ts. This levy will 
fund the state services dealing with the harms caused by 
alcohol, and public health counter-advertising. As part of the 
Master Settlement Agreement in 1998 involving 46 states 
in the US, the tobacco industry must provide for the cost of 
treating smoking-related illness, and of funding educational 
programs to reduce underage smoking. This settlement 
amounted to a total of $209 billion to be paid over a period 
of 25 years.3 
Why not just raise taxes?
An increase in taxation may not be successful in curbing the 
sale of cheap alcohol because some retailers, particularly 
supermarkets who sell cheap alcohol and use it as a loss 
leader, can simply absorb tax increases. In addition, taxation 
may have a greater impact on the on-trade, where the 
price of alcohol is already considerably more expensive, 
and where operators will be more likely to pass on the tax 
increase to the consumer. 
What arguments are used to oppose minimum pricing, and 
are these arguments valid?
Opposition to minimum pricing originates mainly from 
the retail and drinks industries, and is broadly along the 
following lines:
• Low-risk drinkers will have to pay a higher price for 
the actions of others. 
Alternative view: It is the harmful drinker and 
not the low-risk drinker who will be most affected. 
Harmful drinkers buy more alcohol than the average 
consumer and are proven to be price sensitive so this 
measure will affect their alcohol consumption. 
• People on low incomes will be penalised. 
Alternative view: Low-risk consumers, irrespective 
of income levels, will notice very little difference in 
terms of cost. What will be noticeable, though, is 
a reduction in alcohol-related deaths and illnesses 
among low earners who experience a lot of the 
harms associated with alcohol.
• Minimum pricing contravenes EU trade law. 
Alternative view: While minimum pricing for 
most products is illegal, the EU treaty states that 
introducing a minimum price for alcohol may be 
allowed provided that it can be demonstrated that 
such a measure is both necessary and proportionate 
to reduce alcohol-related harm. However, the treaty 
states that a minimum price cannot be introduced 
if it is set so low that imported alcoholic products 
are placed at a disadvantage in relation to identical 
domestic products, and also that the alcohol industry 
should not be involved in the process of setting the 
minimum price.
Marketing
The steering group recommends the development of 
legislation to provide for a 9.00pm watershed for alcohol 
advertising on television and radio, limiting alcohol 
advertising in cinemas, and the prohibition of all outdoor 
advertising of alcohol. 
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In a systematic review of 13 longitudinal studies with 
a total sample of over 38,000 young people, there was 
evidence that exposure to alcohol advertising and 
promotion predicted both the onset of drinking among 
non-drinkers and increased levels of consumption among 
existing drinkers.4
Why is it important to delay adolescents from drinking?
An adolescent need drink only half as much as an adult to 
experience the same negative effects, and even occasional 
binge drinking can damage the young brain. MRI (Magnetic 
Resonance Imaging) scans of the brains of 14–21-year-olds 
show that those who abuse alcohol have about 10% smaller 
hippocampi – the area of the brain that handles memory 
and learning and is responsible for decision-making and 
reasoning.5 Those who start drinking at the age of 15 are 
four times more likely to become dependent than those who 
commence drinking at the age of 21.6
Why are the existing Irish voluntary codes not suffi cient in 
reducing young people’s exposure to alcohol marketing?
Voluntary codes in relation to the marketing and promotion 
of alcohol were agreed between the Department of Health 
and the advertising and alcohol industries in 2005. The 
codes state that their purpose is to reduce the exposure of 
young people to alcohol advertising and marketing and to 
limit the overall level of alcohol advertising and sponsorship 
across all media in Ireland. In spite of this stated aim, there 
is no mention in the codes of specifi c targets or timeframes. 
Instead, the codes simply monitor adherence to initiatives 
which may or may not have any impact on the exposure of 
children to advertising.
These codes are insuffi cient for a number of reasons:
• They have no legislative framework.
• They fail to provide effective cover for all forms 
of alcohol marketing, such as new media and 
sponsorship.
• They do not address the increasingly common 
branded events which merge alcohol brands with 
key aspects of youth culture. A cultural or music 
event with an alcohol brand in the title, such as 
Absolut Fringe or the Jameson Dublin International 
Film Festival, can be advertised on radio before 
the watershed as this does not constitute alcohol 
marketing under the existing codes.
• They fail to act as a suitable deterrent to bad 
marketing practices because of weak enforcement 
and lack of stringent penalties. If a breach is upheld 
there is no penalty, the drinks company or advertiser 
is simply asked to remove the offending promotion.
• The reliance on public complaint is of limited 
effectiveness. In many instances, young people are 
the only ones aware of marketing and promotions, 
and they are unlikely to be a critical audience. For 
example, parents may not know what advertising is 
reaching their children through social networking 
sites like Facebook.
Sponsorship by alcohol companies
The steering group recommend that drinks industry 
sponsorship of sport and other large public events in Ireland 
should be phased out through legislation by 2016.
What is the link between sponsorship by alcohol companies 
and harmful use of alcohol?
Sports sponsorship by the alcohol industry provides an 
opportunity to build the alcohol brand into the name of the 
event through mention in sports commentaries, signage on 
clothing and sports grounds, and products retailed to fans. 
Marketing through sports sponsorship attracts young males, 
the group most likely to be heavier drinkers. It also accesses 
audiences when they are most receptive to learning about a 
product – while they are having a good time at an exciting 
branded event. Many sports events are also family affairs, 
and alcohol ‘impressions’ are also made on young people, 
helping form in adolescence the attitudes and preferences 
that are taken on into later life.
Research has shown that young people have a particularly 
high awareness of, and exposure to, sports sponsorship.7 
Events are chosen to show how well the brand understands 
and relates to young people: in an analysis of alcohol 
industry documents, one Carling executive was quoted as 
saying: ‘They [young men] think about four things, we brew 
one and sponsor two of them’.8 In a New Zealand study 
of over 1,200 sports players, ranging from social players 
to provincial/national competitors, alcohol sponsorship 
was reported by 48%. Those who received sponsorship at 
the individual, team or club level were more likely to be 
hazardous drinkers, and had an average AUDIT score (which 
measures harmful drinking) that was 2.4 points higher than 
that of those who received no sponsorship.9
(Deirdre Mongan)
 1. Department of Health (2012) Steering group report on a 
national substance misuse strategy. Dublin: Department of 
Health. http://www.drugsandalcohol.ie/16908/
 2. Stockwell T, Auld C, Zhao J et al. (2012) Does minimum 
pricing reduce alcohol consumption? The experience of 
a Canadian province. Addiction, Epub 11 February 2012.
 3. Schroeder SA (2004) Tobacco control in the wake of the 
1998 master settlement agreement. The New England 
Journal Of Medicine, 350: 293-301.
 4. Anderson P, de Bruijn A, Angus K et al. (2009) Impact of 
alcohol advertising and media exposure on adolescent 
alcohol use: a systematic review of longitudinal studies. 
Alcohol and Alcoholism, 44: 229-43.
 5. U.S. Department of Health and Human Services (2007) 
The Surgeon General’s call to action to prevent and 
reduce underage drinking. Washington DC: Offi ce of the 
Surgeon General. www.surgeongeneral.gov/topics/
underagedrinking/calltoaction.pdf 
 6. Grant BF and Dawson DA (1997) Age at onset of alcohol 
use and its association with DSM-IV alcohol abuse and 
dependence: results from the National Longitudinal 
Alcohol Epidemiologic Survey. Journal of Substance Abuse, 
9: 103-10.
 7. Gordon R, Moodie C, Eadie D et al. (2010) Critical social 
marketing - The impact of alcohol marketing on youth 
drinking: qualitative fi ndings. International Journal of 
Nonprofi t and Voluntary Sector Marketing, 15: 267-275.
http://oro.open.ac.uk/20461/
 8. Hastings G, Brooks O, Stead M et al. (2010) Alcohol 
advertising: the last chance saloon. BMJ, 340: 184-186.
 9. O’Brien KS and Kypri K (2008) Alcohol industry 
sponsorship and hazardous drinking among 
sportspeople. Addiction, 103: 1961-6.
Steering Group’s recommendations (continued)
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5Trends in treated problem drug use in 
Ireland 2005–2010
A new publication in the HRB Trends Series was published 
in December 2011.1 Trends Series 12 describes trends 
in treated problem drug use in Ireland between 2005 
and 2010, based on data reported to the National Drug 
Treatment Reporting System (NDTRS). The analysis 
presented in this paper provides service planners and policy 
makers with valuable information in order to highlight and 
address problem drug use. 
The main fi ndings of the analysis are summarised below. 
Numbers treated
It is important to note that each record in the NDTRS 
database relates to a treatment episode (a case), and not to 
a person. This means that the same person could be counted 
more than once in the same calendar year if he/she had 
more than one treatment episode in that year. 
The number of cases entering drug treatment each year 
and reported to the NDTRS increased by 52%, from 5,176 
in 2005 to 7,878 in 2010. The increase in the total number 
of people requiring drug treatment services, including 
previously treated cases returning to treatment, is a strong 
indication that problematic drug use remains a pressing 
issue, and presents complex and multiple challenges to 
those providing treatment. The clear spread and increase in 
treated drug use throughout the country refl ect not only the 
extent of problem drug use but also an increase in treatment 
availability and compliance with the NDTRS.
Problem substances
Opiates (mainly heroin) were the most common problem 
drugs reported for all years, with the proportion of opiate 
users remaining stable between 2005 and 2008 but 
decreasing slightly in the following two years. The number 
of cases reporting cannabis as their main problem substance 
increased signifi cantly over the reporting period, from 1,039 
in 2005 to 1,893 in 2010. Following a steady increase to a 
peak in 2007, the number of cases reporting cocaine as their 
main problem substance decreased in the subsequent two 
years and remained stable in 2010. Head shop compounds 
were reported as a main problem substance for the fi rst 
time in 2009 (17 cases), with the number increasing 
signifi cantly to 213 cases in 2010, when it exceeded the 
numbers reporting amphetamines, ecstasy and volatile 
inhalants. Among new cases, benzodiazepines accounted 
for the highest proportional increase among the fi ve most 
commonly reported problem substances (Figure 1). In 2010, 
cannabis became the most common main problem drug 
reported by new cases, ahead of opiates for the fi rst time 
since 2005.
The use of more than one problem substance continues 
to present a challenge to the treatment services. The 
vast majority (68%) of cases treated between 2005 and 
2010 reported problem use of more than one substance. 
Cannabis, alcohol, cocaine and benzodiazepines were the 
most common additional problem drugs reported by all 
cases entering treatment. The very large number of cases 
reporting alcohol as an additional problem substance 
highlights the strong links between alcohol and illicit 
substance use. 
 2005 2006 2007 2008 2009 2010
Opiates 772 913 1037 1169 1221 1172
Cannabis 794 809 695 845 1047 1253
Cocaine 275 342 466 447 417 382
Ecstasy 92 65 86 66 47 21
Benzodiazepines 42 50 85 74 137 140
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Figure 1 Main problem drug reported by new cases entering treatment (NDTRS 2005–2010)
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The profi le of cases entering drug treatment remained 
stable over the reporting period; in general, problem drug 
users were male and in their twenties. Data show that half 
of the new cases entering treatment between 2005 and 
2010 had started drug use at or before the age of 15 years. 
The proportion of new cases aged under 18 years has 
increased since 2007 and reached 16% in 2010. This fi nding 
highlights the need for prevention measures and initiatives 
specially targeted at young teenagers in an attempt to delay 
initiation to drug use. 
Data showed a decline in injecting behaviour and, among 
new injectors, an increasing interval between starting drug 
use and starting injecting. The increase in harm reduction 
services and practices over the reporting period is likely to 
have infl uenced this progress. 
Figures also show that there was a signifi cant decline in 
employment rates among drug users, from 22% in 2005 to 
9% in 2010, a direct indication of the effect of the current 
economic climate. These fi ndings outline the continued 
importance of social and occupational reintegration 
interventions as part of the drug treatment process.
The growing demand for treatment for problem use of 
substances other than heroin, combined with the high 
proportion of cases using multiple problem substances, 
remains a constant challenge for service providers, as drug 
users often require multiple treatment interventions, which 
in turn require a high degree of co-operation between 
services. This inter-agency approach to treatment and 
rehabilitation was highlighted as one of the priorities in the 
current drugs strategy.2 Supported by the drugs task force 
structure, many services are participating to an increasing 
extent in local inter-agency initiatives in order to provide 
a wide range of interventions and a continuum of care 
for clients, for example, through the development of case 
management and key working strategies. 
An online appendix to this Trends Series paper, containing 
additional tables and fi gures with supplementary data, is 
available on the website of the National Documentation 
Centre on Drug Use at www.drugsandalcohol.ie/16381
(Delphine Bellerose)
1. Bellerose D, Carew AM and Lyons S (2011) Trends in 
treated problem drug use in Ireland 2005–2010. HRB 
Trends Series 12. Dublin: Health Research Board. www.
drugsandalcohol.ie/16381
2. Department of Community Rural and Gaeltacht Affairs 
(2009) National Drugs Strategy (interim) 2009–2016. 
Dublin: Department of Community, Rural and Gaeltacht 
Affairs.
Trends in treated problem drug use (continued)
BYAP marks its 30th year with launch of 
two reports 
November 2011 saw Ballymun Youth Action Project (BYAP) 
launch two reports on substance misuse to mark the fi nal 
event celebrating its 30th year. The fi rst report, Seen but 
not heard?, documents the proceedings of a conference on 
substance misuse that took place in Dublin Castle in March 
2011.1 The second report, Fact or fi ction?, looks at young 
people’s attitudes to drugs and alcohol-related issues.2
The conference report, in particular, offers an insight into 
the experiences and issues affecting local communities, 
practitioners and academics. It also highlights the need for 
all agencies working in the fi eld to adopt a more integrated 
approach in addressing the drugs problem. The second 
report offers an insightful picture of the experiences and 
attitudes of young people. It also offers a more personalised 
local perspective than other, larger, general research surveys 
carried out in Ireland.
Dermot King, director of BYAP, said at the launch, ‘The voice 
that comes from within communities affected by drugs 
and alcohol will continue to provide crucial insight and 
understanding in how to deal with these issues.’
Founded in 1981, the Project has been offering a 
community-based response to drug and alcohol misuse 
in the Ballymun area. Congratulations to Ballymun Youth 
Action Project on its 30th anniversary and continued 
success for the future. For further information or to obtain 
a copy of these reports, please call 01 842 8071 or log on to 
www.byap.ie.
(Vivion McGuire)
1. Ballymun Youth Action Project (2011) Seen but not 
heard? Thirty years of communities responding to drugs. 
Dublin: BYAP. www.drugsandalcohol.ie/16442
2. Herbert C and Fennelly C (2011) Fact or fi ction: 
a study of attitudes to alcohol and related issues among 
young people in the Ballymun area. Dublin: BYAP. 
www.drugsandalcohol.ie/16441
At the BYAP launch: Christian Herbert and Cara Fennelly, 
authors of the Fact or fi ction? report
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longer the question 
In the past two decades drug policy researchers have 
sought to move away from the polarised, and increasingly 
unproductive, debate between those supporting the 
prohibition of psychoactive substances under the UN 
conventions and those arguing for legalisation, or some form 
of decriminalisation. Some of the key themes highlighted by 
these researchers are outlined below.1
Acknowledge the complexity
As long ago as 1993, Mark Kleiman argued that debates 
about prohibition versus legalisation or treatment versus 
enforcement represent deeply held beliefs about human 
nature and the human good, which could not be ignored, 
but that more attention to practical detail would improve 
the discussion.2 He emphasised the complexity of the issue: 
there is a large variety of psychoactive substances (including 
alcohol and tobacco), drug users and drug use settings, and 
a wide range of policy response options, including laws and 
programmes, and between them they result in a potentially 
infi nite variety of outcomes. He concluded: ‘Public 
policy toward drugs involves so many unknown, almost 
unknowable facts and so many complicated issues of value 
that any certainty about which of two alternative policies is 
the better is likely to be misplaced.’ (Chapter 13).
More recently Robin Room and Peter Reuter,3 discussing 
whether or not international drug conventions protect 
public health, concluded: ‘The cultural positions of different 
drugs vary enough to preclude universal policies on how to 
deal with all illicit or indeed licit drugs. From the perspective 
of public health, we need to move towards a control system 
that is more aligned with the risks that different drugs pose 
to users and shows an understanding of the effects 
of different regulatory approaches on drug use and harm.’ 
(p. 90).
Focus on harm rather than evil
Reviewing the arguments in favour of prohibition and 
legalisation respectively, Robert MacCoun and Peter 
Reuter concluded that the prohibitionist arguments were 
signifi cantly less complex than the opposing arguments, and 
that it was this very complexity that had served to polarise 
the debate.4 They argued, moreover, that this allegiance 
to ‘prevalence reduction’, and the notion that the only 
defensible goal for drug policy is to reduce the number of 
users, hopefully to zero, had prevented two more moderate 
strategies from receiving serious attention from the political 
mainstream – ‘quantity reduction’ (reducing the quantity 
consumed by those who continue to use drugs) and ‘harm 
reduction’ (reducing the harmful consequences of drug use 
when it occurs). 
Maximise the public good
Six experts in the drug policy fi eld have devised a tool 
to help policy makers to organise the major public drug 
policy options in terms not only of their ‘effectiveness’, e.g. 
in terms of individual benefi t, but also their potential to 
maximise the ‘public good’.5 The ‘public good’ is defi ned 
as ‘social benefi ts such as better public health, reduced 
crime, and greater stability and quality of life for families and 
neighbourhoods’.
The effect of drug policy options on the public good 
and individuals (Strang et al. 2012: p. 79).
The authors argue that this tool, comprising a four-tiered 
pyramid of policy options, is useful in the identifi cation 
of interventions, even though the specifi c problems and 
the most appropriate type of interventions will vary over 
time and between societies and geographical locations. 
They comment: ‘A comprehensive public policy approach 
would implement evidence-based measures at each level of 
intervention and maximise the synergy between these levels. 
Long-term benefi ts of these policies would thus increase for 
whole communities as well as for individuals.’ (p. 80).
Shift the goalposts
British drug policy researchers have recently explored 
how drug policy makers might improve the likelihood 
of achieving desired policy outcomes by reviewing the 
prevailing paradigms and considering a change in the aims 
and objectives of drug policy accordingly. For example, 
on the assumption that the control of drugs is related 
to prevailing conceptions of freedom, Toby Seddon 
suggests that the drugs problem might be best viewed as a 
regulation and governance problem. In place of a legislative 
framework that seeks to use the criminal justice system 
to reduce or eliminate the use of drugs, he suggests that 
in a post-modern world characterised by networked and 
polycentric governance structures, a hierarchy of regulatory 
interventions might be more appropriate – ranging from 
‘persuasion’ at the base, depending on dialogue to secure 
compliance, to higher levels where interventions become 
more punitive and demanding, depending on the drug and 
the context.6 Alternatively, Alex Stevens suggests that drug 
policy might be addressed within the context of a country’s 
equality policy, on the grounds that the distribution of drug-
related harm is determined as much by how welfare policy 
distributes risks and benefi ts, as by the degree of ‘strictness’ 
of drug policy.7 
Acknowledging that the traditional approaches to drug 
control used in the 20th century are no longer effective, as 
they are unable to keep pace with the changes in substances 
and market mechanisms, a new report has called for a new 
approach to policy making:8 
The issue is one of framing. If drug policy is framed as “a 
war on drugs” then it is either won or lost and requires 
a level of national sacrifi ce (wars are won or lost). If it is 
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On 1 January 2013 Ireland will take on the EU presidency, 
just as the current EU drugs strategy (2005–2012) comes to 
an end. It last held the presidency in 2004, when the current 
strategy was being prepared.1 An external evaluation of the 
2005–2012 strategy has been commissioned and was due 
to be completed by the end of 2011. This evaluation will 
inform the development of the new strategy, which will be 
adopted by the European Council.
In a separate initiative launched on 25 October 2011, 
and undertaken in the context of its commitments under 
the 2010–2014 Stockholm Action Plan,2 the European 
Commission announced an overhaul of the EU’s legal 
instruments in the fi ght against illicit drugs.3 Calling 
for a strengthening of the EU’s response to drugs, the 
Commission noted that the EU’s two main anti-drugs legal 
instruments, one relating to drug traffi cking (2004/757/
JHA) and one to the emergence of new psychoactive 
substances (2005/387/JHA), were both over six years old. 
The Commissio n considers that new challenges, including 
new ways of traffi cking drugs and drug precursors, the 
emergence of new drugs, and innovative distribution 
channels, all justify the development of new legal 
instruments. Moreover, the Commission believes the 
entry into force of the Lisbon Treaty and the dismantling 
of the pillar structure in EU policy-making provide fresh 
opportunities for integrating all policy areas relevant to the 
drugs problem. 
The European Commission is proposing:
1. a legislative package revising the Council Framework 
Decision on drug traffi cking and the Council Decision on 
new psychoactive substances; 
2. legislative proposals on drug precursors;
3. legislative proposals on the confi scation and recovery of 
criminal assets and on strengthening mutual recognition 
of freezing and confi scation orders; and 
4. new legislative measures to combat money laundering.
In addition, the Commission is proposing:
5. indicators to monitor drug supply, drug-related crime 
and drug-supply reduction to help improve the 
effectiveness of supply-reduction measures; and
6. minimum quality standards to improve drug prevention, 
treatment and harm reduction services.
In launching this plan of action under the Stockholm 
Programme for the next two years, the European 
Commission has invited the European Parliament and 
the European Council, civil society and other important 
stakeholders to take part in a debate on effective responses 
to illicit drugs and new psychoactive substances. On 28 
October 2011 the Commission launched a 12-week online 
public consultation aimed at gathering the opinions of 
individuals and stakeholders as to the EU-level actions on 
which the Commission should focus in order to best tackle 
illicit drugs and the emergence of new substances that 
imitate them. This consultation closed on 20 January 2012.
Future issues of Drugnet Ireland will provide updates on 
progress in developing the EU drugs strategy and the 
outcome of the European Commission’s public consultation. 
(Brigid Pike)
1. Pike B (2004) Groundwork for new EU drugs strategy to 
be laid during Irish presidency. Drugnet Ireland, (10): 1.
2. On 10–11 December 2009 the European Council 
adopted the Stockholm Programme, a comprehensive 
framework of initiatives in justice and home affairs. The 
political objectives in this programme were translated 
into concrete actions for adoption in 2010–2014 
(COM (2010) 171 fi nal). In the Stockholm Action Plan 
the European Commission is tasked with introducing 
measures to reinforce protection against serious and 
organised crime.
3. European Commission (2011) Towards a stronger 
European response to drugs. COM (2011) 689/2. 
framed as the “drug problem” then there is an implicit 
assumption that there is a “solution” (problems have 
solutions). An alternative way of looking at the issue is 
to use systems thinking and consider drug policy as a 
“wicked issue” to which there is no solution, and no 
winners or losers. Instead, one seeks an improvement to 
policy that will be supported by people who otherwise 
disagree about what is wrong and what the goals of 
policy are. (p. 12). 
Based on the output from ‘soft-system workshops’ attended 
by a variety of stakeholders, the authors identifi ed three 
broad principles for improving drug policy: (1) focus on 
achieving outcomes where there is consensus, (2) ensure a 
more balanced decision-making process and debate, and (3) 
consider other regulatory options for control. 
(Brigid Pike)
1. The authors cited in this article have all participated in 
annual conferences of the International Society for the 
Study of Drug Policy (ISSDP). For more information on 
the ISSDP, see www.issdp.org 
2. Kleiman MAR (1993) Against excess: drug policy for results. 
New York: Basic Books. Electronic copy downloaded on 
16 January 2012 at http://www.sppsr.ucla.edu/faculty/
kleiman/book/ 
3. Room R and Reuter P (2012) How well do international 
drug conventions protect public health? The Lancet, 379 
(9810): 84–91.
4. MacCoun RJ and Reuter P (2001) Drug war heresies: 
learning from other vices, times & places. Cambridge: 
Cambridge University Press.
5. Strang J, Babor T, Caulkins J, Fischer B, Foxcroft D and 
Humphreys K (2012) Drug policy and the public good: 
evidence for effective interventions. The Lancet, 379 
(9810): 71–83. For an account of a previous study on 
drug policy and the public good, to which fi ve of these 
six authors contributed, see Pike B (2010) Using scientifi c 
knowledge to inform drug policy. Drugnet Ireland, (34): 
11–12.
6. Seddon T (2011) A history of drugs: drugs and freedom in 
the liberal age. Abingdon: Routledge.
7. Stevens A (2011) Drugs, crime and public health: the 
political economy of drug policy. Abingdon: Routledge.
8. Birdwell J, Chapman J and Singleton N (2011) Taking 
drugs seriously: a Demos and UK drug policy commission on 
legal highs. London: Demos .
To prohibit or not to prohibit (continued)
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This section contains short summaries of recent reports and 
other developments of interest.
Amphetamine: a report on the illicit market in Europe 
This joint publication by the European Monitoring Centre 
for Drugs and Drug Addiction (EMCDDA) and the European 
Police Agency, Europol, is an in-depth study of the illicit 
market in amphetamine.1 Combining law enforcement 
data on measures such as drug seizures and detections of 
clandestine laboratories with drug-use prevalence data, 
the report shows that Europe is the world’s number one 
producer of amphetamine and a major consumer market. The 
highest levels of amphetamine use in Europe are reported in 
Norway, Denmark, Latvia and the UK, and the lowest levels in 
Greece, Cyprus, Malta and Romania. Ireland does not feature 
prominently in the report. Amphetamine seizures in Ireland 
decreased from 277 in 2006 to 89 in 2010.2
Cannabis, possible cardiac deaths and the coroner 
in Ireland
A recently published article examined the role of cannabis 
in cardiac deaths in Ireland.3 Of the 3,193 coronial cases 
processed between 2009 and 2010 by the Department of 
Chemical Pathology based in Beaumont Hospital, 99 had a 
positive screening immunoassay for cannabis in the urine. 
Thirteen of these cases had enough clinical information 
provided to indicate a cardiac cause of death, and were 
included in the study. 
This group of cases had a median age of 47 years (range 17 
to 61 years), and 11 were male. Myocardial infarction was 
the primary cause of death in 54% (7) of cases. In only one 
case was cannabis mentioned on the death certifi cate, and 
then not as a cause of death. Other causes of death included 
sudden adult death syndrome, sudden death in epilepsy, 
and poisoning by alcohol and diazepam. The author states: 
‘To attribute death due to cannabis smoking, published 
evidence indicates that the trigger window is about 2 h 
[two hours] and that plasma cannabis values are required 
to estimate the time of cannabis usage.’ None of the cases 
included in this paper had plasma tetrahydrocannabinol 
(THC) measured.
In conclusion, the author suggests that plasma THC should 
be measured where urine cannabinoids are positive. He 
states: ‘A positive urine cannabinoids immunoassay alone is 
insuffi cient evidence in the linkage of acute cardiac death 
and cannabis.’ 
(Contributors Johnny Connolly and Ena Lynn)
1. EMCDDA and EUROPOL (2011) Amphetamine: a 
European Union perspective in the global context. 
Luxembourg: Publications Offi ce of the European Union. 
www.emcdda.europa.eu/publications/joint-publications/
amphetamine
2. Irish Focal Point (2011) 2011 National Report (2010 data) 
to the EMCDDA by the Reitox National Focal Point. Ireland: 
new developments, trends and in-depth information on 
selected issues. Dublin: Health Research Board.
3. Tormey WP (2012) Cannabis, possible cardiac deaths and 
the coroner in Ireland. Irish Journal of Medical Science, 
Online First. 10 January 2012. www.drugsandalcohol.
ie/16772
British–Irish Council discusses recovery 
from problem drug use 
On 13 January 2012 the British–Irish Council (BIC) held its 
17th summit meeting, hosted by the Irish government, in 
Dublin Castle.1 The Council welcomed a discussion paper on 
recovery from problem drug use. Policy ministers discussed 
drug treatment measures and strategies that have been 
put in place in each administration to facilitate the path of 
recovery. The Council noted that a more ambitious approach 
was needed involving individual care plans and inter-agency 
working to better address the holistic needs of clients. 
The Council also noted the Misuse of Drugs workstream’s 
commitment to include a renewed focus on recovery from 
drug dependence in any future drugs strategies, with a view 
to maximising the potential for individuals to access the 
social, economic and cultural benefi ts of life. The Council 
agreed that member administrations will actively  encourage 
the renewed focus on recovery and will work together to 
evaluate and share successful approaches.
With regard to the eleven workstreams on which the work 
of the BIC is based, the summit meeting noted the good 
progress and work of each, including the Misuse of Drugs 
workstream, which is led by the Irish administration. Since 
the 16th summit meeting, BIC Misuse of Drugs workstream 
meetings have included a presentation on the review of 
Ireland’s opioid treatment protocol. This presentation 
outlined the history of opiate substitution in Ireland, the 
development of the fi rst set of national protocols, and how 
the opiate situation has changed in Ireland since those 
initial protocols were developed, as well as the key fi ndings 
of the review and their implementation. A more recent 
meeting included two presentations from Northern Ireland, 
the fi rst on fi ndings from a longitudinal research project 
on adolescents, and the second on the tool developed by 
Northern Ireland to measure the impact of their national 
drugs strategy. The workstream also provided the discussion 
paper ‘Recovery from Problem Drug Use’ which was 
discussed at the meeting.
1. The BIC was established under the Agreement reached 
in Belfast on Good Friday, 1998. The governments of 
Britain, Scotland, Wales, Northern Ireland, Ireland, Jersey, 
Guernsey and the Isle of Man are represented on the 
Council. The BIC facilitates co-operation on east-west 
issues between each of the member administrations 
by way of exchanging information, consulting on best 
practice and discussing matters of mutual interest. For 
further information, visit www.britishirishcouncil.org 
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Politicians and the drugs debate – six 
years on
Recent comments by politicians in the Oireachtas and in 
the public arena suggest that the political climate in Ireland 
is becoming more open than it was just six years ago to 
exploring responses to the illicit drug problem other than 
strictly prohibitionist options.1 
In September 2011 members of the Joint Committee on 
Health and Children asked whether it was time to consider 
the drug policy options preferred by Portugal and the 
Netherlands, i.e. eliminate criminal sanctions for illicit drug 
users,2 and whether it was time to consider allowing people 
with a complete physical and chemical dependence on 
heroin or morphine to get their heroin or morphine in well-
supervised, clean, incorruptible circumstances, i.e. establish 
safe injecting facilities.3 Speaking at the second National 
Drugs Conference of Ireland in November 2011, Junior 
Health Minister Róisín Shortall, who is in charge of Ireland’s 
drugs strategy, said she had an ‘open mind’ in relation to 
Portugal’s model.4
 How has this change come about? What factors have 
infl uenced the shifts in thinking? Answers to such questions 
would increase our understanding of Ireland’s policy process 
in relation to illicit drugs, including how the increased 
body of research and information in recent years, and 
different actors and stakeholder groups, have infl uenced 
the policy debate. They would also indicate to what extent 
the development of Ireland’s drug policy is becoming a 
more transparent and democratic process, less shrouded in 
ambiguity, than it has been in the past.5
To answer such questions would require a dedicated research 
effort. Instead, the following article outlines how the drugs 
policy issue may be debated while avoiding the polarised, 
and increasingly unproductive, debate between those 
supporting the prohibition of psychoactive substances under 
the UN conventions and those arguing for legalisation, or 
some form of decriminalisation.
(Brigid Pike)
1.  A report on an Oireachtas debate in 2006 on Ireland’s 
drug policy noted that the speakers did not take the 
opportunity to explore the full range of strategic options 
available. See Pike B (2006) Politicians and the drugs 
debate. Drugnet Ireland, (19): 16–17.
2. Dowds R (2011, 22 September) Parliamentary Debates 
Dáil Éireann (Offi cial report: unrevised): Joint Committee 
on Health and Children debate. Illegal drug use: 
discussion (resumed). http://debates.oireachtas.ie/
HEJ/2011/09/22/00004.asp. 
3. Crown J (2011, 15 September) Parliamentary Debates 
Dáil Éireann (Offi cial report: unrevised): Joint Committee on 
Health and Children debate. Illegal drug use: discussion. 
http://debates.oireachtas.ie/HEJ/2011/09/15/00003.asp.
4. O’Keefe C (2011, 4 November) Minister considers 
Portuguese drugs strategy. Irish Examiner. 
5. Butler S and Mayock B (2005) ‘An Irish solution to an 
Irish problem’: harm reduction and ambiguity in the 
drug policy of the Republic of Ireland. International 
Journal of Drug Policy, 16 (6): 415–422; O’Shea M (2007) 
Introducing safer injecting facilities (SIFs) in the Republic 
of Ireland: “Chipping away” at policy change. Drugs: 
education, prevention and policy, 14 (1): 75–88. 
HSE plans to maximise efficiencies
The HSE’s National Service Plan 2012 (NSP) sets out the 
HSE’s plans for 2012.1 In his introduction to the plan, the 
CEO of the HSE points out that this is the third consecutive 
year in which the organisation has taken a cut in its annual 
budget. Unlike those in previous years, expenditure cuts in 
2012 will begin to impact directly on frontline services.2
The CEO outlines how the HSE plans to minimise this impact 
by ‘fast-tracking new, innovative and more effi cient ways of 
using a reducing resource’ and by moving to models of care 
which ‘treat patients at the lowest level of complexity and 
provide services at the least possible unit cost’. Services in 
the drugs and alcohol area will not be exempt from these 
new approaches. 
The strengthening of ‘multidisciplinary complex care’, 
including the development of protocols signposting referral 
pathways between specialist addiction/homeless/traveller 
services and primary care services, is listed as a ‘key result 
area’ under Primary Care, Demand-Led Schemes and Other 
Community Schemes (p. 26). 
In the delivery of addiction services (Table 1), which 
continue to be co-located with homelessness, intercultural 
health, Travellers’ health, and lesbian, gay, bisexual and 
transgender (LGBT) health services under Social Inclusion 
Services, it is planned to monitor treatment outcomes 
and to analyse methadone waiting lists and exits from 
the Methadone Treatment List on a quarterly basis; these 
actions are noteworthy when set against the performance 
activity report for 2011, which shows that the target of 
100% substance misusers over the age of 18 years for whom 
treatment commenced within one month of assessment was 
not achieved (Table 2). The HSE also intends to review the 
operation of the national drugs rehabilitation framework and 
identify hindrances to care planning/case management at 
the systemic and individual client level.
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Table 1 Addiction services, deliverable outputs 2012 
Addiction services Deliverable outputs 2012
Target 
completion
National Drugs 
Strategy (NDS) 2009–
2013 – implement 
recommendations from 
HSE Opioid Treatment 
Protocol
• Establish a national data collection, collation and analysis group to 
maximise the use of current data, identify new data, and develop a 
brief outcome monitoring process for individuals.
Q1
• Develop joint clinical guidelines on the treatment of opioid addiction 
across the full range of drug services by the ICGP, ICP, PSI and the 
HSE. The guidelines will include an implementation plan for the 
move to less urine testing and a greater clinical focus on the use of 
the results of drug testing samples.
Ongoing
• Produce a quarterly analysis report on methadone waiting lists. Ongoing
• Produce a quarterly analysis report on exits from the Methadone 
Treatment List.
Q2–Q4
Report of the Working 
Group on Residential 
Treatment and 
Rehabilitation 2007 
and HSE National Drugs 
Rehabilitation Framework 
2010
Conduct an analysis of the HSE’s National Drug Rehabilitation Framework 
for usefulness for the following groups: service users, case managers, key 
workers within other disciplines and service managers
Q4
Measure client care plan progression over the course of 2012. Q4
Identify the barriers that hinder care planning/case management at the 
systemic and individual client level.
Q4
Prioritise and implement 
HSE actions in the 
National Substance Misuse 
Strategy (following its 
publication
Develop an annual training plan which targets emerging trends in 
addiction and refl ects best practice via the HSE National Addiction Training 
Programme.
Q1
Implement Quality Standards (Quality in Addiction and Drug Services, 
QuADS) in both the statutory and voluntary-managed addiction services.
Ongoing
Conduct an effectiveness review exercise on all current forms of needle 
exchange provision currently funded by the HSE.
Q4
Launch an Alcohol Public Education/Awareness Campaign. Q1
Further develop web-based information and awareness systems for 
addiction.
Q4
Develop a national drug and alcohol service directory to include in-depth 
information on treatment and rehabilitation and geo-mapping for staff and 
service (linked with HSE Health Intelligence Unit and Health Atlas).
Q3
Source: NSP 2012, pp. 68–69.
Table 2 Performance activity and indicators 2011 and 2012 (from NSP 2012, p. 70)
 
Notwithstanding the budget cuts, new initiatives are 
fl agged for 2012. In line with recommendations in the 
revised HSE Opioid Treatment Protocol, implementation of 
new clinical guidelines on the treatment of opioid addiction 
will see less urine testing and a greater clinical focus on the 
results of drug-test samples. Following publication of the 
National Substance Misuse Strategy, the HSE will adopt a 
new addiction training plan, implement quality standards 
across all addiction services, and develop a series of new 
information and awareness initiatives. Needle exchange is 
HSE plans to maximise efficiencies (continued)
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another new focus for the HSE in 2012. As well as reviewing 
the effectiveness of all needle exchange provision which 
it is currently funding, the HSE is aiming to recruit 90 
pharmacists to provide the needle exchange programme. 
The target set in last year’s service plan, to complete by the 
end of 2011 an analysis of addiction services for children 
nationwide based on best practice, was not met and has 
been moved out to Quarter 3 of 2012 (p. 60). This action 
was identifi ed in response to Recommendation 3 in the 
Report of the Commission to Inquire into Child Abuse (the Ryan 
Report), on the provision of counselling and educational 
services for children, which called on the HSE and the drugs 
task forces to establish addiction services for children 
nationwide based on best practice by June 2011. 
(Brigid Pike)
1. Health Service Executive (2012) National Service Plan 
2012. Available at www.hse.ie 
2. For an overview of the 2011 objectives, see Pike B (2011) 
HSE plan for drug-related services in 2011. Drugnet 
Ireland, (37): 12–13. www.drugsandalcohol.ie/14994
HSE plans to maximise efficiencies (continued)
Funding drugs services in a recession
Budget 2012 outlines cuts to directly drug-related funding 
under two Votes – Education and Health (see table below).1 
Current funding for education-related projects will drop by 
€132,000 (24%), while funding for pilot projects in drugs 
task force areas across the country, funded under the Drugs 
Initiative, will decrease by just over €2.5 million (7%). 
Against the trend, capital funding under the Drugs Initiative 
will increase by 38%.
Vote: Subhead 2011 Estimate (€000) 2012 Estimate (€000)
Change 
2012 over 
2011
Current Capital Total Current Capital Total
Education: Funding of 
Projects in Drugs Task 
Force Areas
543 - 543 411 - 411 -24%
Health: Drugs Initiative 33,044 623 33,667 30,475 1,000 31,375 -7%
Source: Department of Finance (2011)
In 2010, in anticipation of a decline in its funding, one 
regional drugs task force commissioned an independent 
study to evaluate the effi ciency and effectiveness of the 30 
projects it had funded in 2008 and 2009, to undertake a 
needs assessment with regard to substance misuse in the 
region, to score the capacity of the evaluated projects to 
meet these needs, and to prepare a roadmap to ensure it 
continued to use its resources in the most effective way 
possible.2 Using the Rapid Assessment Response (RAR) 
method promoted by the World Health Organization (WHO) 
and the European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA), the researchers who undertook the 
three-month study concluded that it is a useful approach for 
service planners and policy makers ‘who often have diffi cult 
funding decisions to make in short time frames and under 
competing pressures’.3
A mix of quantitative and qualitative methods was used to 
gather data relevant to both the needs assessment and the 
performance evaluation:
• analysis of existing data sources on the prevalence 
and nature of the drug problem, to inform a 
retrospective needs analysis; 
• the administration of a standardised needs 
assessment questionnaire to each service, to provide 
the basis for a prospective needs analysis;
• one-to-one qualitative interviews with service 
providers;
• consultations with regional stakeholders; and
• analysis of data collected relevant to service 
effi ciencies, and of each service’s fi nancial and 
monitoring data for the previous year.
The roadmap was developed in round-table discussions by 
the three researchers, based on triangulation and constant 
comparing of all the data gathered in the course of the 
study. This ensured that any inconsistencies in the data 
could be identifi ed, and that the most relevant and effi cient 
projects for the region emerged.
The main recommendations of the roadmap were as follows:
Strategic priorities: A short regional drugs strategic plan 
should be developed, adapting and localising the national 
drugs strategy by prioritising the national pillars of the 
strategy in line with the region’s needs and by setting 
clear measurable targets and outcomes for each pillar. The 
researchers proposed placing the pillars in the following 
order of local priority: (1) Treatment, (2) Rehabilitation and 
(3) Prevention.
Treatment: The roadmap proposed three targets – a drug 
substitution service for opiate users that ensured access to 
100% of opiate users, comparability of local service provision 
to Dublin’s range of services, and availability of mental 
health services to substance misusers within one month 
of referral. 
Rehabilitation: The researchers recommended that the 
region should engage closely with the National Drug 
Rehabilitation Implementation Committee (NDRIC) on 
how to localise its recommendations, and in preparation 
for shared care planning, it should implement a unique 
identifi er system for clients in the region.
Prevention: Although the region had prioritised prevention 
among projects funded, the RAR revealed that work 
methods and approaches to the delivery of preventative 
education were uneven. The researchers suggested that the 
task force and regional service providers should examine 
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the quality standards framework developed by the National 
Drug Education Workers Forum (DEWF). They also suggested 
that resources should be focused on those most ‘at risk’, and 
to this end, ‘targeted’ and ‘selected’ interventions should 
be prioritised while other ‘more generic’ approaches could 
be delivered by organisations working with the regional 
population as a whole. 
Funding: Table 5 in the published report shows how funding 
allocations could be made in accordance with the local 
strategic priorities; thus, funding to projects aligned with the 
top priorities should continue to be funded, funding to other 
projects should continue but their relevance or effi ciency be 
further reviewed; and funding to other projects should be 
suspended, because the project is not of suffi cient strategic 
importance or relevance, or the need could be met by some 
other means.
With regard to research, the roadmap recommended 
that the task force should form ‘a strategic alliance with 
an educational institute in the region in order to assist 
the development of the research pillar for the region’. 
In response to needs identifi ed by services in relation to 
processes and support for projects (including the need 
for enhanced information sharing, the development of 
common working methods and the provision of training), 
the roadmap recommended a review of data collection 
methods and the appointment of a half-time monitoring and 
evaluation position for the region. 
(Brigid Pike)
1. Department of Finance (2011) Comprehensive Expenditure 
Report 2012–2014. Part IV: Estimates for Public Services 
2012 and Summary Public Capital Programme. 
Downloaded on 15 December 2011 from http://budget.
gov.ie/Budgets/2012/2012.aspx 
2. Comiskey C, O’Sullivan K and Milnes J (2011) Regional 
drug user services in times of scarce fi nancial resources: 
using a rapid assessment response approach to evaluate, 
plan and prioritize essential services. Substance Use & 
Misuse, 47 (3): 254–264.
3. The International Journal of Drug Policy (2000) Volume 
11, Issues 1–2, included a series of articles discussing the 
advantages and disadvantages of the RAR method. 
Funding drugs services in a recession (continued)
Make social solidarity a core concern to ensure fairness and unity of purpose
An NESC Secretariat paper, Ireland’s economic recovery: an analysis and exploration, published in July 2011, argued that, 
in order to sustain and deepen the country’s economic recovery, Ireland needs to focus on ‘working the (EU/IMF) deal’ 
rather than debating whether it can work. It outlined fi ve connected elements necessary for ‘working the deal’, including 
making social solidarity a core concern to ensure fairness and unity of purpose, which the authors explained as follows: 
‘In adjusting public expenditure it is necessary to identify innovative ways of cutting costs and maintaining standards. This 
requires engagement of local problem-solving to ensure that expenditure is reduced in a way that does not undermine the 
services provided to citizens.’ The full Secretariat paper is available at www.nesc.ie
Thirteenth annual Service of 
Commemoration and Hope 
On Wednesday 1 February, the Family Support Network 
(FSN) held its thirteenth annual Service of Commemoration 
and Hope, entitled ‘Growing Strong Together’, in 
remembrance of loved ones lost to drugs and related causes 
and to publicly support families living with the devastation 
that drug use causes.
The service in Our Lady of Lourdes Church, Sean McDermott 
Street, was attended by President Michael D Higgins, Ms 
Róisín Shortall TD, Minister of State, Commander Mick 
Treacy, aide de camp to the Taoiseach, Garda Commissioner 
Martin Callinan, Bishop Eamonn Walsh and other religious 
representatives, as well family members, friends and 
representatives from family support groups throughout 
Ireland, and many people working in this area. 
In her address to the gathering, Sadie Grace of the FSN 
emphasised the importance of local family support groups 
working in partnership with local services to enable these 
service to support families. She highlighted current issues 
involving the Network, which include: recommendations to 
government from the FSN bereavement group, the setting 
up of a bereavement support group, nationwide training 
within family support groups, working with gardaí to assist 
victims of intimidation and working on a regional response 
to Garda harassment. She welcomed the Minister’s response 
to alcohol marketing and benzodiazepine misuse and her 
acknowledgement of the important role families play in 
rehabilitation. She mentioned cuts to the Network’s core 
funding and requested decision makers in the audience to 
prioritise the FSN. She fi nished her address with a line taken 
from a previous speech by Minister Shortall, ‘in times of test 
families are best’.
 
‘Growing Strong Together’ – the FSN Service of 
Commemoration and Hope at Our Lady of Lourdes 
Church, Sean McDermott Street (Photo: Michael 
Gallagher)
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Minister Shortall emphasised the family’s critical role 
in rehabilitation and reinforced the message that drug 
addiction can be overcome. She stated that a partnership 
approach is underpinned in the current National Drugs 
Strategy, which aims to tackle drug use in a comprehensive 
way. She recognised the importance of the Service of 
Commemoration and Hope in acknowledging and 
celebrating the young lives of those who had been lost to 
drugs, and in looking forward with hope. 
The growth of family support groups throughout 
Ireland was evident at the Service. At the fi rst Service of 
Commemoration and Hope in 2000, less than 10 family 
support groups, all located in the Dublin area, were 
represented. At this year’s service over 100 groups from 
across the island of Ireland were represented.
President Higgins recited the poem ‘For Grief’ by John 
O’Donohue. In his address to the gathering, Bishop Walsh 
stressed the importance of supporting families, especially 
children from families who have been affected by drug 
addiction. 
For many families, this service is the fi rst time that they can 
openly grieve for their loved ones lost to drug use and related 
causes. Personal testimonies were given by members of family 
support groups, refl ecting the vital support received through 
these groups. Music was provided by the soprano Nickola 
Hendy and the Gardiner Street Gospel Choir.
(Ena Lynn) 
Contact the Family Support Network at 16 Talbot Street, 
Dublin 1. Tel: 01 836 5168; email: info@fsn.ie ; 
web: www.fsn.ie
Thirteen annual Service of Commemoration and Hope (continued)
Study findings on opiate substitution 
programme for adolescents 
There is not a lot of Irish or international research to inform 
or guide service providers on treatment pathways for 
adolescents receiving opiate substitution treatment (OST). 
Smyth and colleagues recently conducted a retrospective 
cohort study looking at the outcomes for heroin-dependent 
adolescents receiving OST in Dublin, and the incidence of 
hepatitis C, HIV and mortality among this group.1
The Young Persons Programme (YPP), a multidisciplinary 
adolescent treatment service provided by the Drug 
Treatment Centre Board (DTCB), accepts adults aged 17 
years or under (and 18-year-olds occasionally). Based in 
Dublin, it also provides treatment to young people from 
surrounding counties. The programme is ‘harm reduction 
orientated’ but overall the aim is to assist clients to 
abstinence through detoxifi cation. 
The authors studied the records of heroin-dependent 
adolescents who were referred to the YPP between May 
2000 and July 2008. Adolescents with a dependence on 
prescription opioids and those who dropped out of the 
assessment process before starting on medication were 
excluded from the study. The study cohort comprised the 
fi rst 100 patients who met the inclusion criteria. Information 
on participation in the programme was recorded at 3, 6 and 
12 months.
Doctors working at the DTCB were permitted to prescribe 
buprenorphine when it became available as a treatment 
option in 2005. Nineteen of the cohort were prescribed 
buprenorphine at the start of treatment, while all others 
received methadone. The mean peak methadone dose 
prescribed over the treatment period was 53mg (range 
15mg to 90mg). 
Three quarters of the 100 adolescents were aged 16 or 
17, and 13 were aged 15 or under. There were more girls 
(54, 54%) than boys (46, 46%). There were statistically 
signifi cant differences between the boys and the girls. 
Boys were more likely than girls:
• to have left school at a younger age 
(13.8 years versus 14.9 years [mean]);
• to report that a sibling abused opiates 
(56% versus 32%);
• to have previous criminal convictions 
(59% versus 29%);
• to have ever been imprisoned (41% versus 14%).
Girls were more likely than boys:
• to have a current partner who used heroin 
(16% versus 64%).
The fi nal progression route of the adolescents was the 
primary outcome of interest for the authors. The route of 
exit was recorded for 92 clients who left or moved on from 
the treatment programme: 
• 22% (20) had a planned discharge following detox;
• 32% (29)  dropped out;
• 8% (7) were imprisoned;
• 39% (36) transferred to another service to continue 
opiate substitution.
Twenty-eight adolescents dropped out during their fi rst year 
of treatment, 19 of whom left within the fi rst three months. 
Boys were signifi cantly more likely than girls to leave 
treatment because of imprisonment (14% versus 2%). 
Of the 49 adolescents who remained in treatment for 12 
months and for whom urinalysis results in the 12th month 
were available, 39% (19) were completely abstinent from 
heroin. There was no statistically signifi cant difference 
between boys and girls.
The study also looked at the incidence of blood-borne 
viruses and mortality:
• 20% were hepatitis C positive (17 of the 84 tested);
• 33% of injectors were hepatitis C positive 
(12 out of 36 tested);
• no clients were HIV positive (0 out of 69 tested);
• no deaths were recorded during treatment.
The authors noted the relatively long assessment process 
for admission to the treatment programme. They point out 
that, while only 12 adolescents dropped out during the 
assessment phase, ‘a faster route into treatment may have 
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resulted in more study participants and may have altered 
the detected outcome profi le’. Boys were signifi cantly 
more likely than girls not to progress from assessment to 
treatment, which may be linked to the fi nding that slightly 
more girls than boys were treated in the programme 
over the study period. This differs from what is shown in 
the national data, where the majority (73%) of cases in 
treatment for problem opiate use are male.2 
While the adolescents who remained in treatment showed 
reductions in heroin use, the authors caution that, ‘heroin 
dependence represents a complex and serious clinical 
problem and poses major treatment challenges’. These 
challenges include high drop-out rates, especially in the 
early months of treatment, along with the proportion who 
never complete detoxifi cation or who relapse. The authors 
conclude that many adolescents with heroin dependence 
will require opiate substitution treatment for at least a year 
or more. 
(Suzi Lyons)
1. Smyth B, Fagan J and Kernan K (2012) Outcome of 
heroin-dependent adolescents presenting for opiate 
substitution treatment. Journal of Substance Abuse 
Treatment, 42(2): 35–44.
2. Carew AM, Bellerose D, Lyons S and Long J (2009) 
Trends in treated problem opiate use in Ireland, 2002 to 
2007. HRB Trends Series 7. Dublin: Health Research 
Board. www.drugsandalcohol.ie/12371
Opiate substitution programme (continued)
Detoxification: the evidence on setting 
and intervention
An expansion in the number of residential detoxifi cation 
beds has been recommended by the Working Group on 
Drugs Rehabilitation (2007)1 and endorsed by the National 
Drugs Strategy (Interim) 2009–2016.2 While the provision 
of effective detoxifi cation services is acknowledged as a key 
component of rehabilitation and recovery from substance 
addiction, it is important to understand the impact of 
different settings and interventions for detoxifi cation to 
improve the evidence base and promote best practice. This 
article summarises the evidence from one systematic review 
and one randomised controlled trial (RCT) concerning 
the most effective setting for detoxifi cation and one 
systematic review that compared different interventions for 
detoxifi cation. 
Evaluating the setting in which detoxifi cation takes place
Day and colleagues3 looked for RCTs comparing inpatient 
detoxifi cation programmes with other types of opiate 
withdrawal programmes (outpatient programmes) to 
ascertain what was more effective. They found only two trials, 
only one of which, from 1975 and involving 40 patients 
receiving methadone substitution treatment, satisfi ed the 
inclusion criteria. The results of that trial suggested that 
inpatient detox might be more effective in the short term: 
70% of the inpatient group were opioid free on discharge, 
compared to 37% in the outpatient group. However, all of the 
inpatients had relapsed within three months of detoxifi cation. 
The authors’ conclusions and their notes for practitioners state 
‘…there is very little available research to guide the clinician 
about the longer-term outcomes or cost-effectiveness of 
inpatient or outpatient approaches’. 
Day and Strang4 undertook an RCT on the impact of 
treatment setting on detoxifi cation. In the trial, 68 opioid-
dependent patients (most were in receipt of methadone 
and all but six were also using heroin) were randomised 
to an inpatient or an outpatient setting. Participants in 
both settings received the same structured lofexidine 
detoxifi cation treatment. More inpatients (51%, 18) than 
outpatients (36.4%, 12) completed the detox but the 
difference was not statistically signifi cant. This meant that 
less than half of the 68 patients randomised to the different 
detoxifi cation settings managed to complete the treatment. 
Eleven participants in all were abstinent from all opioids at 
one-month follow-up, and only eight at six-month follow-
up, with no superior differences between the groups. The 
authors state: ‘The results of [this] trial confi rm previous 
research fi ndings that detoxifi cation is an ineffective stand-
alone treatment for opioid dependence.’
Evaluating different interventions for detoxifi cation
Amato et al.5 compared the effectiveness of any 
psychosocial plus any pharmacological intervention 
with any pharmacological intervention alone for opioid 
detoxifi cation. Eleven studies including 1,592 participants 
met the inclusion criteria for the review; these included both 
RCTs and non-randomised trials. The authors concluded 
that ‘psychosocial treatments offered in addition to 
pharmacological detoxifi cation treatments [methadone 
or buprenorphine] are effective in terms of completion of 
treatment, use of opiate results at follow-up and clinical 
attendance’. However, they also state that ‘the evidence is 
limited due to the small numbers of participants in the trials 
and differences in assessments from the trials’. On the other 
hand, they do contend that it may be desirable to combine 
both psychosocial and pharmacological approaches to make 
detox more effective. 
(Martin Keane)
1. Working Group on Drugs Rehabilitation (2007) National 
Drugs Strategy 2001–2008: rehabilitation. Report of 
the Working Group on drugs rehabilitation. Dublin: 
Department of Community, Rural and Gaeltacht Affairs. 
www.drugsandalcohol.ie/6267
2. Department of Community, Rural and Gaeltacht Affairs 
(2009) National Drugs Strategy (interim) 2009-2016. Dublin: 
Department of Community, Rural and Gaeltacht Affairs.
3. Day E, Ison J and Strang J (2008) Inpatient versus other 
settings for detoxifi cation for opioid dependence. 
Cochrane Database of Systematic Reviews. Published 
online 8 October 2008. http://onlinelibrary.wiley.com/
doi/10.1002/14651858.CD004580.pub2/full
4. Day E and Strang J (2011) Outpatient versus inpatient 
opioid detoxifi cation: A randomised controlled trial. 
Journal of Substance Abuse Treatment, 40(1): 56–66.
5. Amato L , Minozzi S, Davoli M and Vecchi S (2011) 
Psychosocial and pharmacological treatments versus 
pharmacological treatments for opioid detoxifi cation. 
Cochrane Database of Systematic Reviews. Published 
online 7 September 2011. http://onlinelibrary.wiley.com/
doi/10.1002/14651858.CD005031.pub4/full
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CRA, ACRA and CRAFT: a brief review of 
the evidence
The Community Reinforcement Approach (CRA) is 
acknowledged in the National Drugs Strategy as an effective 
evidence-based approach that could be used as an adjunctive 
to services delivered within the rehabilitation pillar. 
Roozen et al. (2004) undertook a meta-analysis of 
11 randomised controlled trials (RCTs) to review the 
effectiveness of two approaches to treating substance 
abuse: (i) Community Reinforcement Approach (CRA) 
versus usual care, and (ii) CRA versus CRA with contingency 
management. A qualitative analysis was also performed 
using a four-level rating system (Table 1). 
The authors report that there is strong evidence that CRA 
is more effective than usual care in reducing the number of 
days alcohol is consumed, and confl icting evidence on its 
effectiveness in maintaining continued abstinence. There is 
moderate evidence that CRA with disulfi ram (Antabuse) is 
more effective than usual care with disulfi ram in reducing the 
number of days alcohol is consumed, and limited evidence for 
no difference in effect between CRA with disulfi ram and usual 
care with disulfi ram on continuing abstinence. 
There is strong evidence that CRA with ‘incentives’ is 
more effective than usual care in achieving abstinence 
from cocaine use. There is strong evidence that CRA with 
abstinent-contingent incentives is more effective than 
CRA without abstinent-contingent incentives in achieving 
abstinence from cocaine use. 
There is limited evidence that CRA with incentives is more 
effective than usual care in an opioid detox programme 
and there is limited evidence that CRA on its own is more 
effective than usual care in achieving abstinence through a 
methadone maintenance programme.
Table 1 A four-level rating system to assess the strength 
of scientifi c evidence 
1 Strong evidence Consistent fi ndings in 
multiple high-quality RCTs
2 Moderate evidence Consistent fi ndings in one 
high-quality RCT and in 
one or more low-quality 
RCTs, or consistent 
fi ndings in multiple low-
quality RCTs
3 Limited evidence Only one RCT (of high or 
low quality)
4 Confl icting evidence Inconsistent fi ndings in 
multiple RCTs
Source: After  Van Tulder et al. (2000), cited in Roozen 
et al. (2004)
The review by Roozen and colleagues represents the most 
rigorous analysis of the evidence base on CRA; however, it 
only covers studies undertaken before 2004. No high-quality 
analysis has been located since then. The review is useful 
as it examines the effectiveness of CRA in tackling the use 
and misuse of different substances, both when used alone 
and in combination with medications and contingency 
management incentives. This type of review is a useful 
source of information to a diverse body of practitioners 
working in the substance misuse fi eld. Regarding the 
strength of the evidence base for CRA (pre-2004), the 
authors state: ‘In general, there is limited to moderate 
evidence for the effi cacy of CRA with or without medication 
or contingency management in various substance-related 
disorders, including alcohol, cocaine and heroin.’ 
Abbot (2009) reviewed published research on the use of CRA 
in the treatment of opioid dependence. The review included 
three randomised and one non-randomised controlled trials. 
The review is different from that of Roozen et al. in that 
Abbot summarises the fi ndings from the four trials whereas 
Roozen and colleagues synthesise the fi ndings from 11 trials 
to compute a new and overall estimate of effectiveness. 
Abbott concludes that CRA, when combined with 
methadone reduces opioid use and use of other drugs and, 
in one study, improved legal status, reduced psychiatric 
symptoms and improved social and vocational functioning. 
When combined with vouchers (contingency management), 
CRA can retain people in treatment long enough to achieve 
detoxifi cation from buprenorphine. 
In a study undertaken in a less clinical setting than 
previous studies, Slesnick et al. (2007) randomly assigned 
96 homeless young people aged 14-22 to a CRA and 84 
homeless youth to treatment as usual (TAU) at a homeless 
drop-in centre in the US. Homeless youth assigned to CRA 
showed greater improvement in respect of substance use, 
social stability and depression from baseline to six months 
compared to those assigned to TAU. However, those 
receiving TAU also showed improvement in several domains. 
Acknowledging the design limitations of the trial and the 
need for caution when drawing conclusions from these 
outcomes, the authors note that ‘the research design is 
limited in that youth were only assessed at post-treatment. 
A longer follow-up is needed to determine stability of 
treatment effects.’ 
Smith et al. (2008) describes the CRAFT programme as an 
outgrowth of the CRA. The CRAFT programme works with 
concerned family members to rearrange contingencies in 
the alcohol abuser’s environment so that alcohol abuse in 
discouraged and sobriety is encouraged. The ultimate goal 
of the CRAFT programme is to equip concerned family 
members with the skills to infl uence the alcohol abuser 
to engage with treatment. Smith and colleagues provide 
a brief review of a number of both randomised and non-
randomised studies that evaluated the effectiveness of 
CRAFT in comparison with Al-Anon and other interventions. 
Most of the studies showed that CRAFT was more effective 
in helping concerned family members to persuade the 
substance abusers to engage with treatment. However, the 
data provided are much too brief to enable a rigorous critical 
appraisal of the studies. 
An additional recent outgrowth of the CRA is the Adolescent 
Community Reinforcement Approach (ACRA), which aims 
to make an alcohol- and drug-free lifestyle more rewarding 
than continued substance abuse. In a recent study that 
compared the outcomes of 151 adolescents (aged under 
18) and 152 emerging adults (aged 18–25), who were 
diagnosed with substance misuse disorders and had received 
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the ACRA programme, Douglas et al. (2011) found that 
emerging adults were less likely to be abstinent and had 
more days of alcohol use compared to adolescents after both 
received the ACRA programme. 
(Martin Keane)
Abbott PJ (2009) A review of the Community Reinforcement 
Approach in the treatment of opioid dependence. Journal of 
Psychoactive Drugs, 41(4): 379–385.
Meyers RJ, Villanueva M and Smith JE (2005) The 
Community Reinforcement Approach: history and new 
directions. Journal of Cognitive Psychotherapy, 19(3): 
251–264.
Roozen HG, Boulogn e JJ, van Tulder MW, van den Brink W, 
De Jong CA and Kerkhof AJ (2004) A systematic review of 
the effectiveness of the community reinforcement approach 
in alcohol, cocaine and opioid addiction. Drug and Alcohol 
Dependence, 74(1): 1–13.
Slesnick N, Prestopnik J, Meyers RJ and Glassman M (2007) 
Treatment outcomes for street-living, homeless youth. 
Addictive Behaviours, 32(6): 1237–1251.
Smith JE, Meyers RJ and Austin JL (2008) Working with family 
members to engage treatment-refusing drinkers. Alcoholism 
Treatment Quarterly, 26(1/2): 169–193.
CRA, ACRA and CRAFT (continued)
 Implementing needle exchange 
programmes: the evidence base
The National Drugs Strategy (interim) 2009–20161 prioritises 
the expansion of needle and syringe programmes (NSPs) 
throughout the local and regional drugs task force areas. 
While plans to expand the availability of NSPs are welcome, 
improving access and effectiveness must also be key to the 
aims of the drugs strategy, which include the reduction of 
the prevalence of blood-borne viruses among intravenous 
drug users (IDUs) and the reduction of drug-related deaths. 
Key to improving access and effectiveness is understanding 
how best to organise and deliver NSPs. 
This article summarises the only review that has examined 
the evidence base to determine what works best in the 
organisation and delivery of NSPs.2 The authors reviewed the 
literature since 1990 to determine: 
1. What types of NSP are effective?
2. Which additional harm reduction services offered by 
NSPs are effective?
3. Are NSPs delivered in parallel with, or alongside, opiate 
substitution therapy effective? 
Of 406 articles screened, 16 studies were judged eligible for 
inclusion in the review. 
Two random controlled trials (RCTs) in the US in 2003 and 
2007 were included in the review. The 2003 trial compared 
pharmacy-only sales with NSP plus pharmacy sales; neither 
setting produced superior results for reducing injecting risk 
behaviour. However, IDUs in both groups reduced their 
injecting drug use over time, but group assignment did not 
modify this reduction. The 2007 trial examined differences 
between IDUs attending hospital NSPs and those attending 
community-based NSPs and found that neither setting had a 
superior infl uence on injecting risk behaviours. However, both 
groups reduced their drug use risk behaviours over time. 
Findings from three studies included in the review suggested 
that mobile van services and vending machines attracted 
younger IDUs and IDUs with high-risk profi les. 
Findings from three studies in the USA suggested that 
syringe- dispensation dispensing policies had a limited 
impact on the sharing of needles and syringes but had some 
impact on the re-use of syringes. Where policies put fewer 
limits on the number of syringes exchanged, the re-use of 
syringes for personal use was less likely. 
A study involving a cohort of drug users in Amsterdam3 
reported that full participation in a harm reduction 
programme that combined daily methadone maintenance at 
a dose of 60mg or more with needle and syringe exchange 
(with all needles exchanged) was associated with a lower 
risk of HIV and HCV infection in drug users who had ever 
injected, compared to no participation. The authors of 
that study claimed: ‘To provide needles and syringes only 
or methadone only will not be suffi cient to curb the rapid 
spread of these and other blood-borne infections among DU 
[IDUs]. It is essential to offer a comprehensive programme 
in which both measures are combined, preferably also with 
social-medical care and counselling.’ (p. 1461) 
One RCT compared the effectiveness of case management 
(intervention group) with passive referral (control group) 
among NSP attendees who requested referral to drug 
treatment. Participants who received case management 
were more likely to enter treatment compared to the control 
group. Case management was based on the Strengths 
Based Case Management model which is designed to build 
upon the clients’ strengths. Further analysis suggested that 
the provision of transportation (a lift) to the treatment 
programme was an important ingredient in the case of 
management intervention. 
Another RCT evaluated the effectiveness of motivational 
interviewing (MI) in the treatment interest and treatment 
enrolment of 302 NSP participants. Participants were 
randomly assigned to MI, job-seeking readiness or (iii) 
standard care referral. There was no superior effect of MI on 
treatment enrolment. 
The authors of the systematic review concluded ‘it is diffi cult 
to draw conclusions on “what works best” within the range 
of harm reduction services available to IDUs. Further studies 
are required which have a stated aim of evaluating how 
different approaches to the organisation and delivery [of] 
NSPs impact on effectiveness.’ 
(Martin Keane)
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1. Department of Community, Rural and Gaeltacht Affairs 
(2009) National Drugs Strategy (interim) 2009–2016. 
Dublin: Department of Community, Rural and Gaeltacht 
Affairs.
2. Jones L, Pickering L, Sumnall H, McVeigh J and Bellis 
BA (2010) Optimal provision of needle and syringe 
programmes for injecting drug users: a systematic review. 
International Journal of Drug Policy, 21(5): 335–342.
3. Van Den Berg C, Smit C, Van Brussel G, Coutinho R and 
Prins M (2007) Full participation in harm reduction 
programmes is associated with decreased risk for human 
immunodefi ciency virus and hepatitis C virus: evidence 
from the Amsterdam Cohort Studies among drug users. 
Addiction, 102(9): 1454–1462.
Needle exchange programmes (continued)
Evaluating the Strengthening Families 
Programme
Sixsmith and D’Eath (2011)1 were commissioned by the 
Western Region Drugs Task Force to evaluate the roll-out 
of the Strengthening Families Programme (SFP) in fi ve 
centres in the region. The SFP was developed in the USA to 
build resilience and reduce risk factors for poor health and 
social outcomes, including substance misuse and related 
behaviours, in at-risk families. This article describes the main 
fi ndings of the evaluation as they relate to seven specifi c 
questions posed by the evaluators. 
Was the SFP implemented as planned; what, if any, were 
the deviations from the plan; and what were the reasons 
for the deviations?
Steering committees comprising multi-agency representation 
were convened in all fi ve centres as planned. However, 
levels of participation varied across committees, with several 
experiencing non-involvement of individuals and agencies. 
In one of the centres, plans to implement the SFP were 
abandoned because of inadequate levels of participation on 
the committee. For some steering committees, the referral 
system did not work as planned. Referral processes varied 
across the centres and some did not receive any referrals 
from the committees. 
The steering committees, for the most part, decided the 
criteria for referral to the SFP. However, these decisions 
exhibited a lack of clarity and consensus as to the 
appropriate target groups. Steering groups reported 
inconsistencies around understanding which risk factors 
were relevant to determining eligibility for the SFP. For 
example, groups differed on whether substance use was a 
risk factor, and, if it was, how the nature and extent of the 
risk was to be assessed. These inconsistent views were at 
variance with the overall aim of the SFP, which, according 
to the task force, was to reduce substance misuse by both 
parents and teenagers. 
What were the perspectives of participating parents and 
teenagers on the SFP content and delivery?
The delivery of the SFP by a facilitator was valued by 
participants and the variety of activities, including role play, 
games and art, contributed to an unexpected fun experience; 
it was this experience that appeared to engage and sustain 
involvement. Teenagers seemed to learn more from specifi c 
modules, such as substance misuse, sexuality, communication 
and resolving confl ict. On the other hand, parents tended to 
speak about their learning in general terms. 
Was the mealtime an important element of the SFP for 
participants?
Parents, teenagers and service providers considered the 
mealtime an important component of the SFP. The mealtime 
preceded each of the 14 weekly sessions and was seen to act 
as an ice-breaker, providing an opportunity for less formal 
communication between families and providers and within 
families. Some families expressed the desire to incorporate 
this experience into family living.
 Was the training adequate for facilitators to deliver the 
SFP, overall and in this setting?
An information seminar and a two-day training session were 
delivered in each of the four sites. Overall, there were mixed 
views on the adequacy of training, with several facilitators 
saying that the training was only adequate because of the 
range of skills they already possessed and that essential 
skills were neither provided nor tested during the training 
provided. 
What alterations to the process and programme 
(implementation and content) are necessary to ensure 
successful outcomes in future delivery?
Changes to the referral process and greater clarity about 
the role of the referral agencies were identifi ed as necessary 
improvements. In addition, improved clarity in identifying 
relevant target groups and in recruitment processes 
were perceived as necessary changes that could improve 
implementation and impact. Service providers suggested 
that future programmes could focus on families with 
children who were younger than the 12–16-year age group 
stipulated by the current SFP. This suggestion was based 
on the view that younger children were more amenable to 
behaviour change, and that some teenager participants in 
the current SFP exhibited challenging behaviours. 
Did the SFP impact on participants, and if so what was 
the impact?
Families were assessed before and after their participation 
in the SFP, using three domains in the Family Environment 
Scale (FES): family cohesion, expressiveness and confl ict. 
According to the authors, the small sample size and poor 
response rate to some questions interfered with the analysis 
that was planned; the limited data generated meant that no 
signifi cant differences between pre and post intervention 
were detected. 
Interviews with family members suggested that some 
benefi ts from participation in the SFP were achieved, such 
as improved communication within the family unit and 
enhanced parenting skills. 
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Did the SFP reduce drug and alcohol use among 
participants?
Parents were invited to answer questions drawn from the 
SLAN questionnaire about their alcohol intake and related 
behaviours, before and after their participation in the SFP. 
The authors report that too few participants answered some 
questions, which interfered with meaningful analysis. From 
the limited number of questions answered, no measurable 
impact on alcohol intake or related behaviours was detected. 
Teenagers were invited to answer questions drawn from 
the Health Behaviour in School-aged Children (HBSC) 
questionnaire about their substance use and related 
behaviours, before and after their participation in the SFP. 
The authors report that the amount and consistency of 
data generated from responses was inadequate to allow a 
meaningful statistical analysis. From the data generated, no 
differences in substance use can be credited to participation 
in the SFP. 
Interviews with parents (n=10), teenagers (n=7) and service 
providers (n=9) revealed that, for most of the families taking 
part in the SFP, substance use was not perceived to be a 
major problem. 
Conclusion
The lack of consensus on appropriate target groups and on 
what constitutes an at-risk family could have been overcome 
by a thorough needs assessment of potential participants. 
The lack of clarity between participants and service providers 
regarding the main objectives of the programme could have 
been resolved by setting short-term objectives, such as the 
reduction of identifi ed risk factors, rather than focusing on 
long-term and perhaps unrealistic outcomes such as the 
reduction or cessation of substance use. The inclusion of 
alternative outcomes would have necessitated the selection 
of alternative data collection instruments. Instead of using 
modifi ed versions of the SLAN and HBSC surveys, alternative 
instruments could have been used to assess the impact of 
the SFP on participants. 
(Martin Keane)
1. Sixsmith J and D’Eath D (2011) An independent evaluation 
of the Strengthening Families Programme in the WRDTF 
Region. Galway: Western Region Drugs Task Force. www.
drugsandalcohol.ie/16657
Evaluating the Strengthening Families Programme (continued)
The lived experience of those on 
methadone maintenance in Dublin North 
East
Van Hout and Bingham1 were commissioned by the client 
forum of Dublin North East Drugs Task Force to undertake 
an exploratory study of the experience of individuals in 
receipt of methadone maintenance who had engaged with 
the Special Community Employment scheme. Data were 
collected through in-depth interviews with 15 men and 11 
women. The main issues to emerge from the interviews are 
described in the report and are summarised in this article. 
Experiences of methadone
Getting access to prescribed methadone was reported 
as being relatively straightforward, with the main criteria 
for access being the provision of three urine samples that 
tested positive for heroin use. Some interviewees reported 
moving to weekly take-home supplies of methadone 
after providing clean urines for 16 weeks. Although some 
interviewees agreed with the practice of regular urine 
testing, the majority, and especially women, perceived this 
practice as embarrassing and degrading. Most of the people 
interviewed, particularly the women, gave examples of 
improved daily functioning when they replaced the use of 
street drugs with daily doses of methadone. 
Interviewees reported a lack of therapeutic dialogue between 
themselves and the doctors and clinic staff prescribing 
methadone. Issues mentioned in this context included not 
being informed of the physical side-effects of methadone, 
and an absence of clinical advice and support on dosage 
reduction or detoxifi cation. Arising from the absence of 
therapeutic dialogue, interviewees expressed ambivalence 
around detoxifi cation, with some preferring indefi nite 
maintenance instead of potentially painful withdrawal, while 
others expressed frustration at the prospect of long-term 
maintenance and signalled intentions to eventually detoxify. 
Several interviewees talked about their dependence on 
methadone and their fear of the withdrawal symptoms 
if they tried to detoxify; they perceived a detoxifi cation 
from methadone as more diffi cult than coming off heroin 
and perceived methadone as being more addictive than 
heroin. Many saw their daily dependence on methadone as 
restricting their personal freedoms, with some referring to 
methadone as ‘a ball and chain’. 
Many of the interviewees felt stigmatised because of 
their heroin addiction and, although they were receiving 
prescribed methadone, they also felt ashamed of being seen 
by neighbours when frequenting the methadone clinics and 
the pharmacies. 
 Experiences of recovery, progression and Special 
Community Employment schemes
The meaning of recovery and rehabilitation differed among 
participants: for some it meant being on methadone and not 
using the main problem drug, i.e. heroin, while for others it 
meant the cessation of all substance use. The improvement 
in quality of life and the pursuit of mainstream norms such 
as employment and a settled family life were also cited as 
meaningful components of recovery. 
The majority of participants reported that their engagement 
with the Special Community Employment schemes was 
a positive experience. Accounts varied as to the nature of 
these experiences and included improvements in personal 
development and addiction management strategies and 
the development of positive daily structures. For some 
participants, the value of the schemes lay in interaction they 
had with other participants who were ‘clean’ and with staff 
who a listening ear and support. The effectiveness of the 
schemes in developing vocational and employment skills 
was less pronounced; however, some participants reported 
that they had developed literacy and computer skills. Several 
participants expressed the aspiration of progressing to third-
level education from the schemes. 
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The variety of experiences narrated in this report is 
testament to the diverse needs of this cohort of people – 
needs which, according to the people themselves, are not 
being met by the provision of other addiction recovery 
supports and services in the area. Participants referred to 
the lack of connectivity between services, having to wait 
long periods to access a counsellor and not having adequate 
information on what services were available to promote 
and support progression and social reintegration. Several 
participants noted a lack of tangible outcomes for those 
who attended the employment schemes. For example, there 
was a feeling that employers would be prejudiced against 
potential applicants due to their engagement with such 
schemes, gaps in their curriculum vitae and a lack of formal 
education and training qualifi cations. Several noted the lack 
of aftercare and support for those that exit the schemes. 
Conclusion
This report, although exploratory in nature, and confi ned to 
the context-specifi c location of the Dublin North East Drugs 
Task Force area, provides a welcome insight into the lived 
experience of people in receipt of prescribed methadone 
and accessing the Special Community Employment schemes. 
The reported absence of therapeutic dialogue between 
prescribers of methadone and clients can lead to confusion 
and frustration among clients around dosage reduction, 
detoxifi cation and dependence on long-term maintenance. 
The Special Community Employment schemes serve the 
personal development needs of participants but do not help 
to develop educational skills and improve employability, the 
role they were established for. Several participants expressed 
the aspiration of progressing to third-level education from 
the schemes but could not envision how this aspiration 
could be tested and fulfi lled. 
While both interventions, either separately or combined, 
contributed to some improvements in the lived experiences 
of the people interviewed the authors found that they were 
delivered in a way that prevented meaningful progression 
for participants. They conclude: ‘It appeared that not only 
was methadone maintenance treatment a “holding pattern” 
for heroin users, but Special Community Employment 
schemes also operated in a similar fashion, with little real life 
employment preparation, assistance in seeking and securing 
employment or vocational skills development.’ (p. 44)
(Martin Keane)
1. Van Hout M C and Bingham T (2011) Holding pattern: 
an exploratory study of the lived experiences of those on 
methadone maintenance in Dublin North East. Dublin: 
Dublin North East Drugs Task Force. 
www.drugsandalcohol.ie/16231
Methadone maintenance (continued)
Legal update 2011
This update covers drug-related Acts and Bills of the 
Oireachtas introduced or progressed since the Government 
came to offi ce on 9 March 2011.
• The Road Traffi c Act 2011 (No 28 of 2011) provides 
for the amendment to existing legislation to permit 
the early introduction of mandatory alcohol testing 
of drivers of mechanically propelled vehicles in 
certain circumstances, including involvement in road 
traffi c collisions. The Act also clarifi es the position 
regarding mandatory preliminary breath testing.
• The Criminal Justice (Community Service) 
(Amendment) Act 2011 (No 24 of 2011) The 
primary purpose of this Act is to introduce a 
requirement on a court before which an offender 
stands convicted of an offence for which a sentence 
of up to 12 months’ imprisonment would be 
appropriate, to consider imposing the alternative 
sentence of a community service order. Although 
the Bill does not mention specifi c offences, many 
offenders whose offences are committed as a 
consequence of drug addiction receive short 
custodial sentences and could benefi t from the terms 
of this legislation.
• The Criminal Justice (Public Order) Act 2011 (No 
5 of 2011) prohibits harassment or intimidation of 
members of the public by persons who engage in 
begging and confers powers on members of the 
Garda Síochána to give directions to persons to 
desist from begging, in certain circumstances such 
as where they are begging near cash machines or 
in front of places of business. It also provides for 
a series of sanctions including fi nes and possible 
imprisonment for breaches of the law.
• The Communications (Retention of Data) Act 
2011 (No 3 of 2011) requires service providers, 
those engaged in the provision of a publicly available 
electronic communication service or a public 
communication network by means of fi xed line 
or mobiles or the internet, to retain data relating 
to fi xed and mobile telephony for one year, and 
data relating to internet access, internet email and 
internet telephony for two years, and provides for 
disclosure in relation to the investigation of specifi ed 
offences, including customs offences.
Status of Bills before the Dáil
Current status of relevant Bills is shown in the table below.
The full legislative programme for the forthcoming Dáil 
session was published by the Government in January 2012 
and is available at the following link: www.taoiseach.gov.ie/
eng/Taoiseach_and_Government/Government_Legislation_
Programme
(Johnny Connolly)
Title and explanatory memorandum Status 
The Spent Convictions Bill 2011 provides that in the case of convicted persons whose 
sentence is below a specifi c threshold, they may, under certain circumstances, withhold 
details of the conviction. This is intended to apply where a prison sentence not exceeding 
six months or a fi ne or penalty have been imposed, and then only after a certain number of 
years have elapsed without a further conviction. The purpose of the Bill is to help rehabilitate 
convicted persons through facilitating their reintegration into the workforce and allowing 
them to build new careers. 
Referred to Select 
Committee 08/06/2011
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 Launch of Ana Liffey Strategic Plan 
2012–2014
The Ana Liffey Drug Project launched its new strategic plan1 
on 20 January 2012. This document, informed by feedback 
from many stakeholders, will shape the work and aims of the 
organisation through the next three years.
Dublin’s Lord Mayor, Andrew Montague, who formally 
launched the strategy, congratulated Ana Liffey staff for their 
hard work and for the ambitious goals they are setting in 
this new plan. He spoke of the value of pilot projects, even 
those that could be controversial. He declared his support 
for Ana Liffey’s plan to pilot a medically supervised drug 
consumption room in order to fi nd out what effect it might 
have on the wider community, and whether it could reduce 
the overall harm of drug use in the Irish context.
Tony Duffi n, director of Ana Liffey, briefl y highlighted the 
progress made and the challenges faced by the organisation 
in the last fi ve years. He said that the project now offered a 
wider range of services to meet the growing demand from 
service users. There had been a signifi cant increase in the 
numbers of staff and of drop-in contacts between 2007 and 
2011. However, levels of funding had not kept pace with 
these developments, and the project was now having ‘to do 
more with less’. He said that the heroin drought in 2010 had 
had an effect on services, and also on service users, many of 
whom had turned to benzodiazepines and other substances. 
The availability of head shop products (prior to the ban in 
2010), especially mephedrone, along with an increase in 
violence and intimidation, were among the major challenges 
faced by both the staff and the people they worked with. 
Ana Liffey’s plan for 2012–2014 includes six strategic 
objectives, as described below. 
1. To maintain and develop a range of high quality low 
threshold services which support our service users to 
access integrated pathways and achieve their goals.
This objective is internally focused on service delivery. 
The main goal is to establish and strengthen inter-
agency partnerships and to provide easy access to a 
wide range of services in order to support and meet the 
changing needs of each individual.
2. To create service responses which will address the 
unmet service user needs.
This objective is the most controversial part of the plan, 
and was the focus of most questions and comments 
at the launch. The goals under this heading are to 
advocate, plan and work towards the establishment of a 
pilot medically supervised injecting centre by December 
2014, and of a crisis centre for residential detoxifi cation 
specifi cally aimed at tackling the issue of multiple 
substance use by December 2013.
3. To promote quality service delivery in the sector 
through the provision of practical organisational 
supports and initiatives.
In relation to the work done through the Progression 
Routes Initiative, the plan reiterates Ana Liffey’s 
commitment to the QuADS support project. This 
objective also includes the national roll-out of the 
Community Detox Initiative, as well as the co-ordination 
and evaluation of a naloxone pilot targeted at drug 
users, their peers and families, both by December 2014. 
4. To develop appropriate partnerships in order to 
advance our strategic objectives.The goals set by the 
organisation cannot be achieved without the support of 
all stakeholders. In this objective, Ana Liffey emphasises 
the importance of monitoring opportunities to progress 
those objectives on an ongoing basis.
5. To communicate the vision, mission and values of 
the organisation so that individuals with problem 
substance use issues are treated with dignity and 
respect.
A communication strategy will be developed that 
includes annual reviews of services so that stakeholders 
can effectively support service delivery.
6. To develop the capacity of the organisation at all 
levels to enable delivery of the strategy.
In the current diffi cult economic context, it is vital that 
the organisation fi nds ways to optimise resources, using 
tools such as a client management system and a learning 
and development plan for staff.
In his director’s report, Tony Duffi n acknowledged that Ana 
Liffey anticipates ‘continuing challenges over the next three 
years. Not least because of the signifi cant challenges to 
delivering on some of our goals…’. 
Ana Liffey’s mission remains to work with people affected 
by problem substance use and the organisations that assist 
them in order to reduce harm to individuals and society, 
and to provide opportunities for development of those 
individuals and organisations.
(Delphine Bellerose)
1. Ana Liffey Drug Project (2012) Strategic plan 2012–2014. 
Dublin: Ana Liffey Drug Project. Available at www.aldp.ie
At the launch of Ana Liffey’s Strategic Plan: Mr Tony 
Duffi n, director of Ana Liffey, Cllr Andrew Montague, 
Lord Mayor of Dublin, and Mr Pat Carey TD
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Changing patterns of drug use impact 
on services and communities
How have changing patterns of drug use impacted 
on individuals, communities and treatment services in 
recent years? In a seminar hosted by the Dales centre in 
co-operation with CityWide Drugs Crisis Campaign in 
December 2011, several speakers addressed this question. 
Declan Andrews, chairperson of the Dales centre, stated 
that the shift in Dublin from what had been essentially a 
heroin problem to what was now an increasingly complex 
problem of multiple substance use had put a lot of pressure 
on services. He said that this was a serious challenge for all 
addiction treatment providers, especially in a context where 
funding cuts were having a dramatic impact on the delivery 
of such services. 
Presenting the results of a survey done in Darndale, 
Samantha Parkes of the Dales centre described a change in 
the drug of choice among users in that small community. In 
the years 2004–2007, a huge increase in cocaine use had led 
to the implementation of a specifi c cocaine support service 
at the centre. Interviews conducted in 2011 with drug 
users in that area revealed an increase in the use of cocaine 
and crack cocaine, particularly in cocaine used with other 
substances such as alcohol, benzodiazepines and head shop 
drugs. Heroin, now often ranked as a fourth or fi fth drug of 
choice, had not come back to the level of popularity it had 
prior to the heroin drought in 2010. Many drug users had 
replaced heroin with crack cocaine or benzodiazepines, the 
latter more common among women. 
The wide availability of, and easy access to, substances 
contributed to some degree of acceptance within the 
community, facilitated by the legal status of some of 
those substances (alcohol, benzodiazepines, and head 
shop substances prior to the 2010 ban). In the last four 
years, cannabis had become so widely available and 
relatively cheap that its use, sometimes in conjunction with 
mephedrone, had increased dramatically. The cannabis 
strains currently available were far more potent than those 
in recent years; it was noted that the reduced availability of 
hash, the resin form of cannabis, had led to the promotion 
of stronger herbal forms of cannabis on the market, with 
‘skunk’ now commonplace. In 2011, methylamphetamine, 
known as ‘crystal meth’, appeared to be increasingly present 
on the drug scene and was now being used instead of crack 
cocaine in some areas.
The Darndale survey also showed that substances such as 
cocaine, head shop products and benzodiazepines did not 
carry the same stigma as that associated with heroin, and 
that drug users, and indeed the wider community, did not 
view the use of such substances as a serious problem that 
required intervention. Addiction treatment was still often 
viewed by service users as a response to heroin use. Dermot 
King, director of Ballymun Youth Action Project, outlined the 
diffi culty faced by services in addressing the normalisation 
and the social acceptance of benzodiazepine use in the 
Ballymun area. The increased use of benzodiazepines among 
young people who had never used opiates refl ected a 
perception that benzodiazepines were safer and better to use 
than stimulants or opiates. Mr King described an initiative in 
Ballymun involving a close partnership between addiction 
counsellors and general practitioners in order to illustrate the 
positive outcome that some community responses have had 
in the area. 
Johnny Connolly of the Health Research Board spoke of the 
value of local surveys and small-scale research projects in 
revealing what can be hidden in national data or surveys. 
He said that, while levels of crack cocaine use in Ireland 
remained low, increased use in the last few years had tended 
to be hidden behind an overall decrease in the reporting 
of cocaine powder use in national fi gures. He said that 
because the drug problem differs from one area to another, 
and within local areas, the community approach was 
complementary to policies, monitoring and interventions 
implemented at national level, and was a key element of any 
adequate and effi cient response to the drug problem.
Drugs are changing, they are more toxic, there is easy 
access to a wider range of substances and therefore more 
opportunities for potentially lethal combinations. Gary 
Broderick, director of the Saol project, said that there was 
a growing population of stable ex-opiate users who were 
returning to treatment for misuse of cocaine or other 
substances. Multiple substance use, now the norm, increases 
the complexity of drug interventions and is associated 
with poorer treatment outcome and the need for repeated 
episodes of treatment. This is a huge challenge for services 
in a context where already stretched resources are being 
further reduced.
(Delphine Bellerose)
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 Social exclusion and crime
A position paper by the Irish Penal Reform Trust highlights 
the causative connection between social exclusion, 
deprivation and crime.1 The paper argues that marginalised 
communities are more heavily policed and that those from 
such communities receive more severe punishment than 
those from more affl uent communities. It also argues that 
cuts to community-based services will exacerbate crime 
rates. Speaking at the launch of the paper, Liam Herrick, 
director of the IPRT, stated:2
Austerity measures which see cuts to health, education 
and other key services impact disproportionately on 
marginalized communities… increasing levels of social 
exclusion which will have a negative impact on crime.
Other speakers who addressed the launch, which was jointly 
organised by the IPRT and Community Platform (www.
communityplatform.ie), included John Lonergan, former 
governor of Mountjoy Prison and a patron of the IPRT, 
Kathleen Lynch, professor of equality studies at University 
College Dublin, Tony Geoghegan, chief executive of 
Merchants Quay Ireland, Orla O’Connor, head of policy at 
the National Women’s Council of Ireland and Brid O’Brien of 
the Irish National Organisation of the Unemployed.
The paper explores the social profi le of prisoners and the 
‘specifi c ways in which the criminal law is unduly focused on 
marginalised groups’ (p.9). The IPRT calls for the cessation 
of the practice of imprisonment for non-payment of fi nes, 
citing research which found that ‘fi ne defaulters had an 85% 
likelihood of returning to prison after release’ (p.9). The 
paper is also critical of the Criminal Justice (Public Order) Act 
2011, which prohibits some forms of begging, describing it 
as ‘a regressive legislative measure, which unduly penalises 
the most vulnerable members of society’ (p.11). The paper 
highlights the links between substance misuse and crime and 
is critical of the recent budgetary cuts for projects in drugs 
task force areas (p.17). With regard to the reintegration 
of offenders upon release from prison, the paper calls for 
adequate resources to be applied to Integrated Sentence 
Management so that prisoners are adequately prepared for 
their release, ‘receiving assistance with accommodation, 
mental health and/or addiction supports’ (p.18). 
Highlighting the fact that ‘Ireland is the only EU state 
without spent convictions legislation’,2 the IPRT calls for the 
speedy enactment of the proposed Spent Convictions Bill 
so that individuals convicted of minor criminal offences can 
be aided in their attempt to reintegrate back into society 
(p.20). The IPRT also highlights the disproportionate way in 
which offenders of different socio-economic backgrounds 
are treated by the Irish criminal justice system. According 
to Herrick, ‘That we continue to imprison thousands of 
people every year for not paying fi nes, while those involved 
in “white collar” crime remain largely unpunished, further 
underscores Ireland’s disproportionate punishment of some 
sections of society.’2 
The paper forms part of the IPRT’s Shifting Focus campaign 
(www.iprt.ie/shifting-focus), which uses evidence and 
research to support its call for a movement away from 
traditional criminal justice responses to issues of social 
exclusion and associated crime and to demonstrate to policy 
makers that such a shift, ‘– with emphasis on prevention and 
early intervention – makes social and economic sense’.2
(Johnny Connolly)
1. Irish Penal Reform Trust (2012) The vicious circle of social 
exclusion and crime: Ireland’s disproportionate punishment 
of the poor. IPRT Position Paper 9. Dublin: IPRT. 
www.iprt.ie/position-papers
2. Irish Prison Reform Trust (2012) Punishing cuts to 
prevention services will exacerbate unfairness of criminal 
justice system. Press release issued by the Irish Penal 
Reform Trust, 2 February 2012. 
www.iprt.ie/contents/2279
Mandatory minimum sentencing
The Law Reform Commission (LRC) has highlighted in a 
consultation paper a number of serious defi ciencies in the 
operation of the presumptive 10-year sentence for certain 
drug offences and has recommended that the provision be 
reviewed.1 
The consultation paper begins with a consideration of 
the overall aims of criminal sanctions and the principles 
by which these are regulated. The broad aims of criminal 
sanctions as identifi ed by the LRC include punishment, 
deterrence, reform and rehabilitation, and reparation. These 
form the basis of its analysis of presumptive sentencing 
in drug offences. The Criminal Justice Act 1999 created 
a new offence of possessing controlled drugs having a 
value of £10,000 (€13,000) or more for sale or supply, 
which attracted a presumptive sentence of 10 years’ 
imprisonment, except where there were ‘exceptional and 
specifi c circumstances’ relating to the offence, or to the 
person convicted of the offence (p.101). According to the 
LRC, the changes introduced in this legislation ‘marked an 
important turning point in the Irish sentencing regime which 
had until 1999 – with the exception of the sentences for 
murder and capital murder – accorded primacy to judicial 
discretion in the determination of sentences’ (p.102). This 
occurred ‘against a backdrop of an escalating drug problem 
and a growing realisation that Ireland had become a portal 
not only to the Irish drugs market but also to the British and 
European drugs markets’ (p.102).
In the years immediately following these provisions 
however, the courts appeared resistant to allowing their 
discretion to be eroded in this way. The LRC paper cites a 
Department of Justice report on judicial sentencing practices 
for drug offences under section 15A,2 which concluded 
that ‘the courts showed a marked reluctance to impose 
the mandatory minimum sentence … for fear that it would 
result in a disproportionate sentence in individual cases’ 
(p.105). That research found that, out of 55 cases between 
November 1999 and May 2001, a sentence of 10 years or 
more had been imposed in only three cases.
The LRC also suggests that further legislation was introduced 
to address this ‘apparent rift which had developed between 
legislative intent and judicial execution’ (p.102). Introducing 
drugnet 
IRELAND
24
the Criminal Justice Bill 2004, the Government announced 
that it would be making a series of legislative amendments in 
order to strengthen the presumptive sentencing provisions 
for drug offences. In its fi nal form, the Criminal Justice Act 
2006 created a new offence of importing drugs having a 
value of €13,000, which would attract a minimum sentence 
of 10 years. In addition, it introduced provisions to oblige 
the court to consider evidence of previous drug traffi cking 
provisions. It also clarifi ed that the mens rea3 regarding 
the value of the drugs was not an element of the offence. 
Consequently, ‘the prosecution needed only to establish that 
the accused knew that he or she was in possession of drugs 
with intent to supply and not that he or she knew the value 
of the drugs involved.’ During the committee stages of the 
Criminal Justice Bill, the then Minister for Justice, Michael 
McDowell TD, alluded to the apparent rift between the 
intentions of the Oireachtas and the practice in the courts at 
that time:
By enacting the 1999 Act, the Oireachtas gave a clear 
statement to the Judiciary that convictions for drug 
offences involving the sale or supply of substantial 
quantities of drugs should attract signifi cant custodial 
sentences. …[T]he wishes of the Oireachtas have not 
been refl ected in practice. For the fi rst fi ve years of 
its operation, the mandatory minimum sentence was 
applied in only 6% of convictions. (p.107). 
The Minister concluded by noting that for the year 2004, 
‘after public controversy grew, the fi gure was approximately 
21%’ (p.107). Clearly, the changes made had the desired 
effect for the Government.
The LRC however, following a lengthy consideration of 
the way in which the various components of the sentence 
have been adjudicated in practice in the courts, highlights 
a number of criticisms of the presumptive sentencing 
regime.4 As a consequence of the constraints it places on 
the exercise of judicial discretion, the LRC suggests that the 
regime has created ‘a discriminatory system of sentencing 
where all cases are treated alike regardless of differences in 
the individual circumstances of the offenders’ (p.189). The 
LRC also refers to an assertion that the sentence is akin to a 
‘one-strike rule’ (p.131). In this regard the LRC refers to the 
observation of one sentencing expert5 that ‘by contrast to 
the “three strikes” laws enacted in some US states’, the Irish 
regime ‘does not require the accused to have a previous 
conviction for drug dealing or anything else before the 
presumptive minimum may apply’ (p.131). 
The LRC also states, ‘it has been observed that the majority 
of those being caught for offences under section 15A are 
drug couriers rather than drug “barons”’. Those at the 
higher levels of the drugs trade have simply adapted to the 
sentencing regime by using expendable couriers or ‘victims 
of circumstance’, such as ‘impoverished individuals from 
African countries or underprivileged Irish citizens’ to hold 
and transport drugs thus avoiding detection themselves 
(p.132). The regime has also, the LRC concludes, subverted 
the normal criminal process by leading accused people to 
plead guilty simply to avoid the sentence, rather than testing 
the prosecution case.6
In recommending a review of the sentencing regime, the 
LRC states that the legislation has merely led to a ‘bulge 
in the prison system comprising low-level drugs offenders’ 
serving lengthy prison sentences, and that it has not 
contributed to any reduction in levels of criminality (p.189). 
(Johnny Connolly)
1. Law Reform Commission (2011) Consultation paper: 
mandatory sentences. Dublin: Law Reform Commission. 
www.lawreform.ie. The LRC uses the term presumptive 
as distinct from mandatory sentence in that there is 
a presumption that the sentence would apply unless 
the court deems otherwise in a specifi c case. The LRC 
distinguishes such sentences from mandatory life 
sentences for murder treason or capital murder, for 
example. See discussion on p.3 of the LRC paper.
2. McEvoy P (2005) Research for the Department of Justice 
on the criteria applied by the courts in sentencing under 
section 15A of the Misuse of Drugs Act 1977 (as amended). 
Dublin: Department of Justice, Equality and Law Reform. 
www.inis.gov.ie/en/JELR/Research.pdf/Files/Research.pdf
3. A fundamental principle of criminal law is that a crime 
consists of both a mental and a physical element. Mens 
rea, a person’s awareness of the fact that his or her 
conduct is criminal, is the mental element, and actus 
reus, the act itself, is the physical element.
4. A recent Supreme Court decision, in the case of DPP v. 
Connolly (2011) IESC 6, overturned a 10-year sentence 
because of concerns about the way in which the market 
value of a drug seizure was determined. See Connolly 
J (2011) Supreme Court overturns mandatory drug 
sentence. Drugnet Ireland, (38): 15.
5. O’Malley T (2006) Sentencing law and practice. 2nd 
edition. Dublin: Round Hall. p. 340.
6. See discussion on p.119 of the LRC paper. The McEvoy 
study referred to above found that the accused pleaded 
guilty in all but one of the 55 cases studied. McEvoy 
suggests that the ‘the consequences of unsuccessfully 
testing the prosecution case…are so severe, it would 
seem that one of the practical effects of the section has 
been to discourage the vast majority of accused persons 
from proceeding to trial…’.
Mandatory minimum sentencing (continued)
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In brief
In April 2011 the National Review Panel set up to 
undertake reviews in accordance with Guidance for the 
HSE on for the review of serious deaths including deaths 
of children in care completed its fi rst annual report, for 
March to December 2010. During this period, 22 cases 
of death were notifi ed and eight serious incidents. 
Of the 22 deaths reported, four were drug overdoses. 
www.hse.ie/eng/services/Publications/services/Children/
natreviewpanelannualreport2010.pdf 
On 6 September 2011 the European Parliament adopted 
a resolution on an EU homelessness strategy (B7-
0475/2011) in which, among other things, it urged member 
states to make progress towards the goal of ending street 
homelessness by 2015; called for the development of an 
ambitious, integrated EU strategy, underpinned by national 
and regional strategies, with the long-term aim of ending 
homelessness within the broader social inclusion framework; 
called for a framework, agreed by the European Commission 
and member states, for monitoring the development 
of national and regional homelessness strategies, as a 
central element of the EU homelessness strategy and for 
this monitoring framework to address the progress of the 
member states towards ending street homelessness and 
ending long-term homelessness. www.europarl.europa.
eu/sides/getDoc.do?type=MOTION&reference=B7-2011-
0475&language=EN 
www.feantsa.org/code/en/hp.asp
On 20 September 2011 places on the Community 
Employment scheme that are ring-fenced for people 
being rehabilitated from drugs were the subject of a 
written Parliamentary Question, to which the Minister 
for Social Protection, Joan Burton TD, responded: ‘These 
1,000 community employment places are ring-fenced for 
persons undergoing rehabilitation from drug addiction. 
Specifi c criteria exist for these places and the eligibility for 
participation. These were revised and agreed with the sector 
in 2010/2011. Further work is under way in the context of 
the National Drug Rehabilitation Implementation Committee 
to review the allocation of these places and ensure that 
appropriate referral protocols are in place. Participants 
can be in specifi c drug response projects or may be in 
‘mainstream’ community employment projects. It is my 
intention to ensure the continuation of such projects subject 
to the overall budgetary constraints for the community 
employment programme.’ 
debates.oireachtas.ie/dail/2011/09/20/00177.asp 
Between 10 and 12 October 2011 the Civil Society Forum 
on Drugs, organised by the European Commission, met for 
the 6th year in succession in Brussels. The main objective of 
the meeting was to make recommendations to feed into the 
debate around the new EU Drugs Strategy. The European 
Commission has accorded the Civil Society Forum on Drugs 
the status of a European Commission ‘expert group’, i.e. 
a consultative entity that provides advice and expertise to 
the Commission and its services. 
ec.europa.eu/justice/anti-drugs/civil-society/index_en.htm 
On 12 October 2011 the European Centre for Disease 
Prevention and Control (ECDC) and the European 
Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA) co-published Prevention and control of infectious 
diseases among people who inject drugs. It outlines seven 
interventions to reduce and prevent infectious diseases 
among people who inject drugs, ranging from the supply 
of injection equipment, testing and vaccination to the 
treatment of infections and drug dependence. The ECDC–
EMCDDA joint publication is published together with a 
‘Guidance in brief’ summary and with two technical reports 
providing a full assessment of the evidence. 
www.ecdc.europa.eu 
www.emcdda.europa.eu 
On 16 November 2011 the National Drugs Strategy 
2009–2016 was the subject of a ‘topical issue debate’ in 
Dáil Éireann, in the course of which Minister for Health, Dr 
James Reilly TD, stated: ‘ The Government is committed to 
dealing with the scourge of drugs in our community. … Of 
course, the war on drugs will continue, with the involvement 
of law-enforcement and customs offi cers. We will endeavour 
to have more effective treatments. I am not happy with 
the numbers of people who come off methadone and I am 
reviewing that situation. I certainly want it refl ected in any 
new contracts given to doctors who are treating people 
currently on methadone.’ 
debates.oireachtas.ie/dail/2011/11/16/00031.asp
 On 17 November 2011 the Global Initiative for Drug 
Policy Reform was launched at the House of Lords in 
London. It brings together countries interested in reform, 
countries who have successfully implemented alternative 
drug control strategies, and the Global Commission on 
Drug Policy, in order to discuss new evidence and reports 
commissioned by the Beckley Foundation, towards the goal 
of reforming global drug policy, including amendments to 
the UN Conventions. www.reformdrugpolicy.com
On 22 November 2011 Growing up in Northern Ireland by 
Sheena McGrellis was published. It examines the lives of 
18 young people growing up in (and sometimes leaving) 
Northern Ireland between 1990 and 2010. The stories of 
two young women, Cynthia and Adele, among others, show 
how they experienced and negotiated various types and 
levels of risk. Living in areas where paramilitaries continued 
to exercise a level of control even after the ceasefi res, and 
where sectarian attitudes were openly displayed, affected 
the life journeys of both young women. A growing drugs 
culture and a culture of binge drinking, fuelled by the energy 
of an expanding night-time economy, compounded the 
perception, and reality, of risk for many in this generation of 
young people. 
www.jrf.org.uk/publications/growing-up-northern-ireland 
On 15 December 2011, local and regional drugs task 
forces were the subject of a written Parliamentary Question 
from Catherine Byrne TD, to which the Minister of State at 
the Department of Health, Róisín Shortall TD, replied: ‘With 
a view to strengthening their effectiveness, I have initiated a 
review of Drugs Task Forces and the National Drugs Strategy 
structures under which they operate. In this regard, I have 
consulted with the key stakeholders on the future direction 
and role of Drugs Task Forces and this will inform the 
development of reforms in this area. The recommendations 
of a Steering Group on a National Substance Misuse Strategy 
will be published in the New Year. Proposals in regard to a 
Strategy are likely to be considered by Government in the 
Spring and any consequences for Drugs Task Forces arising 
from these will be considered at that stage.’
debates.oireachtas.ie/dail/2011/12/15/00259.asp
(Compiled by Brigid Pike)
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From Drugnet Europe
Best practice portal: bridging the gap
Article by Marina Davili and Marica Ferri in Drugnet Europe, 
No. 77, January–March 2012 
One of the added values of the EMCDDA’s Best practice portal 
(www.emcdda.europa.eu/best-practice) is the synthesis of 
available evidence on the effects of drug demand reduction 
interventions. Having developed a systematic process for 
updating and grading the quality of evidence in the portal, 
the EMCDDA will take another step forward in 2012, with a 
new project to identify knowledge gaps and highlight topics 
for further investigation in this area.
This ‘gap-analysis project’ will proactively garner unanswered 
questions arising from the day-to-day experiences of decision-
makers, practitioners and clients. It will also identify topics 
for the development of guidelines. The project, which is now 
in its protocol phase, encompasses a literature review and 
exploratory interviews with individual practitioners and clients 
from across Europe. The project will result in a structured 
overview of available information and recommendations 
for bridging the identifi ed gaps. Preliminary results will be 
presented to the EMCDDA Scientifi c Committee in May.
Enhancing EMCDDA–ESPAD cooperation
Cited from article by Deborah Olszewski in Drugnet Europe, 
No. 77, January–March 2012
The EMCDDA and the European School Survey Project 
on Alcohol and Other Drugs (ESPAD) are scaling up their 
cooperation in monitoring substance use among 15- to 
16-year-old school students. Their commitment was 
underlined in a joint statement adopted at the 2011 ESPAD 
project meeting, hosted by the EMCDDA in Lisbon 
(www.emcdda.europa.eu/about/partners/espad) 
ESPAD data provide crucial information on substance use 
among school students of this age and are routinely included 
in the EMCDDA’s annual reporting on the drug situation 
in Europe. In the statement, the partners agreed to boost 
technical cooperation to enhance understanding of long-term 
drug use trends in Europe. … Among others, they agreed 
to: develop an enhanced dissemination strategy for ESPAD 
fi ndings and work together to ensure harmonisation of 
methods and support methodological developments. In 2012, 
the partners will be collaborating, for the second time, in a 
joint multilingual publishing project to disseminate the key 
results of the latest ESPAD survey (2011). This summary, 
in 23 languages, is scheduled to be released before summer.
First European quality standards to improve drug 
prevention in the EU
Cited from article by Gregor Burkhart in Drugnet Europe, No. 
77, January–March 2012
Developing and implementing best practice in drug 
prevention in Europe are goals set by the current EU drug 
strategy and action plan. In line with these goals, … [a new 
EMCDDA] manual is the culmination of a two-year project to 
assess existing guidance in this area and to meet the need for 
a commonly agreed European framework to improve drug 
prevention in the EU. … Bridging science, policy and practice, 
over 400 international, European and national experts and 
stakeholders contributed to developing the standards via a 
dynamic process involving focus groups, consultations and 
studies. www.emcdda.europa.eu/publications/manuals/
prevention-standards
EMCDDA launches new multicity project
Cited from article by Liesbeth Vandam and Ana Gallegos in 
Drugnet Europe, No. 77, January–March 2012
The EMCDDA has recently launched a multicity 
‘demonstration project’ to investigate the potential of 
wastewater analysis as an indicator for estimating community 
drug use levels (www.emcdda.europa.eu/wastewater-
analysis). By the end of 2012, the project will have generated 
comparable data from at least 15 European cities, thanks to 
an agreed common sampling approach designed to ensure 
maximum comparability. … By sampling a known source of 
wastewater – for example, a sewage infl uent to a wastewater 
treatment plant – scientists can now obtain estimates of 
the total quantity of drugs consumed by a community by 
measuring the levels of illicit drug metabolites excreted in 
urine. This demonstration project will provide comparable 
information in real time on weekly patterns of use, trends and 
changing consumption habits in the participating cities.
Drugnet Europe is the quarterly newsletter of the European Monitoring Centre 
for Drugs and Drug Addiction (EMCDDA). Drugs in focus is a series of policy briefi ngs published by the EMCDDA. 
Both publications are available at www.emcdda.europa.eu.
If you would like a hard copy of the current or future issues of either publication, please contact: 
Health Research Board, Knockmaun House, 
42–47 Lower Mount Street, Dublin 2. 
Tel: 01 2345 148; Email: drugnet@hrb.ie
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 Recent publications
On our shelves
Books recently acquired by the National Documentation 
Centre on Drug Use.
Addiction dilemmas: family experiences in 
literature and research and their lessons for 
practice
by Jim Orford 
Wiley-Blackwell (2012) 
ISBN: 978-0-470-97701-9
Young people and alcohol: impact, policy, 
prevention, treatment
by John Saunders and Joseph Rey (eds) 
Wiley-Blackwell (2011) 
ISBN: 978-1-444-33598-9
Journal articles
The following abstracts are cited from recently published 
articles relating to the drugs and alcohol situation in Ireland.
Regional drug user services in times of scarce fi nancial 
resources: using a rapid assessment response approach to 
evaluate, plan, and prioritize essential services
Comiskey C, O’Sullivan K and Milnes J 
Substance Use and Misuse, 2012, 47(3): 254–264. 
www.drugsandalcohol.ie/16502
The objective was to assess need, evaluate projects, and 
devise a roadmap for future provision given budget cuts. 
The analysis of 30 substance misuse services in towns and 
rural areas of Ireland was conducted in 2010. Analysis 
revealed that 24,315 (95% CI 12,928–40,629) individuals 
were using illegal drugs in 2006, 893 individuals were 
using opiates, opiate and cocaine use was increasing as 
was drug use amongst females. Evaluations demonstrated 
that not all services were meeting emerging needs, services 
lacked administrative support, and funding needed to be 
redirected. The RAR approach was useful for policy decisions 
and budget cuts in times of economic restraint.
 Prevalence of substance misuse comorbidity in an Irish 
university training hospital
Dixit A and Payne A 
Irish Journal of Psychological Medicine, 2011, 28(4): 201–204.
www.drugsandalcohol.ie/16477
Objective: Substance misuse complicates an individual’s 
management in adult mental health services. This study 
aimed to examine both the overall prevalence of substance 
misuse in those admitted to the psychiatric unit and 
additionally those admitted with a primary diagnosis and 
comorbid substance misuse. The study focuses on the 
associated diagnoses and demographics in 100 consecutive 
admissions to an acute psychiatric unit in an Irish university 
hospital.
Results: The combined prevalence of mental illness and 
substance misuse was 47%. Twenty-two out of 100 (22%)
were admitted primarily for the management of substance 
misuse and dependence (plus psychosocial reasons). Twenty-
fi ve of the patients admitted with a primary psychiatric 
illness (25%) were discovered to have comorbid substance 
misuse. At risk groups were found to be males and aged 
under 45 years.
Conclusion: Our study demonstrates the importance 
of screening and identifi cation for substance misuse in 
psychiatric inpatient units; and consequently, the need for 
individual case management, additional development of 
dual diagnosis services and accurate patient data reporting 
to facilitate forward service-planning.
‘A costly turn on’: patterns of use and perceived 
consequences of mephedrone based head shop products 
amongst Irish injectors
Van Hout MC and Bingham T 
International Journal of Drug Policy, 2012, 16 Feb; 
Early online.
www.drugsandalcohol.ie/17066
Mephedrone injecting has recently been reported in 
Romania, Slovenia, Guernsey and Ireland. This research 
aimed to describe the experiences of a group of Irish 
injecting drug users who were injecting mephedrone-based 
head shop products prior to the introduction of legislative 
controls in Ireland, with particular focus on pre- and post- 
legislation use, effects, settings and contexts for injecting, 
polydrug use and serial drug injecting, risk perceptions and 
harm-reduction practices. 
Conclusion: Continued monitoring of drug displacement 
patterns in post legislative time frames is advised, alongside 
longitudinal ethnographic research to track the diffusion 
of mephedrone and other cathinone derivatives within 
injecting networks. Further investigation of the adverse 
health consequences of these drugs on injection is 
warranted.
Cannabis use: What’s law got to do with it? Perceptions and 
knowledge of cannabis policy from the user perspective in 
Northern Ireland
Stevenson C 
Drugs: education, prevention and policy, 19(2): 129–136. 
www.drugsandalcohol.ie/17069
The aim of this article was to examine attitudes to cannabis 
policy among adults who use the drug in Northern Ireland, 
and to consider these opinions in the context of the UK 
generally and draw parallels with other regions. Data were 
collected through semi-structured interviews with 38 adults 
aged 18–59 with a range of levels of cannabis experience. 
The results showed that people who used cannabis were 
generally unaware of and unconcerned about legal penalties.
Conclusion: Cannabis users tend to consume the drug 
irrespective of policy. The reclassifi cation of cannabis resulted 
in confusion as to what the penalties were, users continued 
to use cannabis irrespective of the law prior to and following 
reclassifi cation and they felt that policy was irrelevant to use.
Reducing the harm from adolescent alcohol consumption: 
results from an adapted version of SHAHRP in Northern 
Ireland
McKay MT, McBride N and Sumnall H 
Journal of Substance Use, 2012, 8 Feb; Early online. 
www.drugsandalcohol.ie/17020
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 Upcoming events
(Compiled by Joan Moore – jmoore@hrb.ie)
May
25–27 May 2012 
Europad 10th International Conference – Heroin addiction and 
related clinical problems 
Venue: Barcelona, Spain 
Organised by / Contact: Europad 
Email: giusi@tigicongress.com 
Web: www.europad.org 
Information: The mission of Europad has always been to 
promote information exchange and updating within the scientifi c 
community, but also to spread an illness-centred conception 
of addictive disorders, with heroin addiction as a long-dating 
prototype. Separate symposia at this conference will be dedicated 
to a bunch of ‘hot’ topics: drug-related morbidity and mortality, 
treatment of special populations, cost-benefi t issue. This year, a 
whole session will concern the issue of long-term discontinuation 
of successful treatment: speakers will deal with the issue of ‘leaving’ 
treatment and of the viability of patient-suggested discontinuation 
in the long-term.
30–31 May 2012
Sixth Annual Conference of the International Society for the 
Study of Drug Policy 
Venue: Cathedral Lodge, Canterbury 
Organised by / Contact: ISSDP 
Web: www.issdp.org/conferences.php
Information: This event will be hosted by the University of Kent 
(School of Social Policy, Sociology and Social Research). The call for 
abstracts is now open. For details, please see ISSDP website. The 
invited keynote speakers are:
Professor Thomas McLellan, University of Pennsylvania 
(formerly Deputy Director of the US Offi ce for National 
Drug Control Policy) 
Dr Michel Kazatchkine, Executive Director of the Global 
Fund and member of the Global Commission on Drug 
Policy. 
Dr Fiona Measham, University of Lancaster and member of 
the UK Advisory Council on the Misuse of Drugs 
Martin Jelsma, Transnational Institute 
The conference will discuss a wide range of drug policy issues, with 
a particular focus on ‘how can and do empirical studies infl uence 
drug policy?’
June
8 June 2012 
Poppy Love: Opioid use and abuse 
11th CARES Conference
Venue: Dundee, Scotland 
Organised by/ Contact: Dundee Medical School 
Email: s.a.marr@dunde.ac.uk 
Web: www.dundee.ac.uk/medschool/medsci/neuroscience/cares/
conferences 
Information: Methadone substitution represents the dominant, 
albeit controversial, treatment intervention for a substantial number 
of people who use illicit heroin. Presently, this programme serves a 
clearly articulated public health and criminal justice-driven agenda. 
There is, however, an implicit assumption that chronic exposure 
to opioids is ‘safe’ or at least ‘safer’ than any other alternatives. 
This international conference will allow leading experts in the fi eld 
to articulate the evidence from recent research fi ndings, bridge 
these fi ndings to clinical settings and provide alternative modes of 
treatment.
The study aimed to trial an adapted version of the School Health 
and Alcohol Harm Reduction Project (SHAHRP) in Northern 
Ireland. The intervention aims to enhance alcohol related 
knowledge, create more healthy alcohol-related attitudes and 
reduce alcohol-related harms in 14–16-year-olds. 
Method: A non-randomised control longitudinal design with 
intervention and control groups assessed post-primary students 
at baseline and at 12, 24 and 32 months after baseline. A total 
of 2,349 participants was recruited at baseline (mean age 
13.84) with an attrition rate of 12.8% at 32-month follow-up. 
The intervention was an adapted, culturally competent version 
of SHAHRP, a curriculum programme delivered in two 
consecutive academic years, with an explicit harm reduction 
goal. Knowledge, attitudes, alcohol consumption, context of 
use, harm associated with own alcohol use and the alcohol use 
of other people were assessed at all time points. 
Results: There were signifi cant intervention effects on all 
measures (intervention vs. controls) with differential effects 
observed for teacher-delivered and outside facilitator delivered 
SHAHRP. 
Conclusion: The study provides evidence of the cultural 
applicability of SHAHRP for risky drinking in adolescents 
in a UK context.
Increased incidence of QT interval prolongation in a population 
receiving lower doses of methadone maintenance therapy
Roy AK, McCarthy C, Kiernan G et al. 
Addiction, 2011, December 11, Early online. 
www.drugsandalcohol.ie/16656
The aim of the study was to investigate the frequency of 
corrected QT interval (QTc) prolongation in a methadone 
maintenance therapy (MMT) population, and to examine 
potential associations between this QT interval and 
methadone dose as well as concurrent use of opiates, cocaine, 
and benzodiazepines. 
Conclusions: Drug-induced QTc interval prolongation is evident 
(ranging from 8.8-11.1%, depending on defi nition applied) 
in patients receiving relatively low daily doses of methadone 
therapy, with no evidence of a dose-response relationships. The 
presence of cocaine metabolites in urine does not appear to be 
associated with increased QTc-interval. Increased awareness of 
cardiac safety guidelines, including relevant clinical and family 
history, baseline, and trough dose ECG monitoring, should be 
incorporated into methadone maintenance therapy protocols.
Recent publications (continued)
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